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Abstract
Objectives
We investigate variations in costs and length of stay (LoS) among hospitals for ten clinical treatments
to assess:
1. The extent to which resource use is driven by the characteristics of patients and of the type
and quality of care they receive;
2. After taking these characteristics into account, the extent to which resource use is related
to the hospital in which treatment takes place;
3. If conclusions are robust to whether resource use is described by costs or by LoS.
Data
We analysed patient-level data from the Hospital Episode Statistics (HES) data for 2007/8, which
contains approximately 16.5 million inpatient records. This dataset was merged with costs derived
from the Reference Cost database.
We extracted data on three medical conditions (acute myocardial infarction (AMI); childbirth;
stroke) and seven surgical treatments (appendectomy; breast cancer (mastectomy); coronary artery
bypass graft (CABG); cholecystectomy; inguinal hernia; hip replacement; and knee replacement).
Methods
For each treatment, we used a two-stage approach to investigate variations in cost and LoS. In stage
I, we ran fixed effects models to explore which patient-level factors explain variations. In stage II, we
regressed the fixed effects from stage I against an array of hospital characteristics.
Results
The number of patients analysed ranged from 18,875 (CABG) to 549,036 (childbirth), and the
number of hospitals ranged from 28 (CABG) to 151 (appendectomy, hernia and hip replacement).
Across the ten treatments, patient factors explained between 32% (stroke) and 72% (breast cancer
and knee replacement) of the observed variation in costs. In the LoS analyses, the corresponding
figures were 28% (stroke) and 63% (hip replacement). A higher number of diagnoses were
consistently associated with higher cost and longer LoS. A higher number of procedures had a
similar effect for 9 of the 10 treatments. The effects of age and gender were mixed, but higher
levels of deprivation were associated with longer stays in 8 of the 10 treatments analysed. LoS was
significantly longer for patients who were cared for by more than one hospital doctor, regardless of
the treatment received. In the seven surgical interventions, wound infection was always associated
with longer stays and usually with higher cost. Emergency admissions increased LoS for all
conditions except stroke.
After accounting for these patient-level factors, substantial variation in costs and LoS among
hospitals was evident for all ten treatments. These variations could not be explained by hospital
characteristics such as size, teaching status, and the amount of the treatment in question that the
hospital performed. We found that average hospital costs or LoS were correlated across similar
types of treatments, notably hernia, cholecystectomy and appendectomy and hip and knee
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replacement. A small number of hospitals had considerably lower average costs or LoS for most
treatments; similarly some hospitals had considerably higher average costs or LoS.
Conclusion
The findings suggest that all hospitals have scope to make efficiency savings in at least one of the
clinical areas considered by this study. A small number of hospitals have higher average costs or LoS
across multiple treatments than their counterparts, and this cannot be explained by the
characteristics of their patients or the quality of care. These hospitals are likely to struggle financially
under Payment by Results (PbR) and need to consider how to improve their use of resources.
A full set of hospital rankings can be accessed via our website:
http://www.york.ac.uk/che/publications/in-house/
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Introduction
When comparing health care providers, variations in practice of any form are often cited as prime
facie evidence of inefficiency or poor performance. If so, the reasoning goes, the overall efficiency of
the health system would improve if all providers were able to meet the standards of the best. But
seemingly sub-standard practice may not be indicative solely of inefficiency. There may be other
influential factors that explain observed practice and it is, therefore, important to take these factors
into account before drawing conclusions about relative efficiency. In this paper we set out and apply
an empirical strategy to account for these factors when comparing costs and length of stay (LoS)
across English hospitals.
We focus on ten different types of treatment using data from 2007/8. The analysis utilises Reference
Cost data reported to the Department of Health (DoH) by English hospitals and recognises that
variation in costs or LoS may be due to the different characteristics of patients receiving treatment in
each hospital. We take this into account by applying a strategy adopted in other studies (Daidone
and Street, 2011, Laudicella et al., 2010) to map each hospitals Reference Cost data to the Hospital
Episode Statistics (HES) which contain detailed information about each patient treated in each
hospital. This allows us to take patient characteristics into account and to compare hospital costs
and LoS purged of the influence of these characteristics. Costs and LoS may be partly due to the
characteristics of hospitals themselves and our comparisons also consider this possibility.
Objectives
This research investigates differences in resource use among patients for ten clinical treatments. We
address three key questions:
1. To what extent is resource use driven by the characteristics of patients and of the type and
quality of care they receive?
2. After taking these characteristics into account, to what extent is resource use related to
the hospital in which treatment takes place?
3. Are conclusions robust to whether resource use is described by costs or by LoS?
Methods
Overview
We analysed patient-level data from the Hospital Episode Statistics (HES) data for 2007/8. We
merged HES data with costs derived from the Reference Cost database. We extracted data on three
medical conditions (acute myocardial infarction (AMI); childbirth; stroke) and seven surgical
treatments (appendectomy; breast cancer (mastectomy); coronary artery bypass graft (CABG);
cholecystectomy; inguinal hernia repair; hip replacement; and knee replacement). For each
treatment, we used a two-stage approach to investigate variations in resource use. In stage I, we
ran fixed effects models to explore which patient-level factors drive variations in cost or LoS. In
stage II, we regressed the fixed effects from stage I against an array of hospital characteristics.
Literature search
To provide a context for our findings we undertook a literature search on the MEDLINE database in
order to identify relevant studies for the paper. We concentrated on papers from 1996 onwards
that identified the drivers of cost and LoS for the ten treatments that we analyse. Search terms
included type of condition, cost, length of stay, and patient characteristics including age, gender,
socio-economic status, emergency cases, mortality, C difficile and urinary tract infection as well as
some condition-specific characteristics.
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Defined by
ICD 10
WHO
OPCS 4.5 codes Diagnosis Exclude Comments
Malignant growth
Breast cancer
diagnosis +
procedure
C50,
D05
B27-B28 main
Age <1, outpatients
(but include day
cases), exclude
males
Cardiovascular diseases
AMI diagnosis
I21,
I22
excl.: K40-K46 main
Age <1, outpatients
(but include day
cases)
Exclude bypass
Coronary artery
bypass graft
procedure K40-K46 all
Age <1, outpatients
(but include day
cases)
Cerebrovascular diseases
Stroke diagnosis
I61,
I63,
I64
main
Age <1, outpatients
and day cases
Gastrointestinal diseases
Inguinal hernia
surgery
Procedure +
diagnosis
K40 T20, T21 main
Age <1, outpatients
(but include day
cases)
Appendectomy
Procedure +
diagnosis
K35-
K38
H01, H02
excl: H024
main
Age <1, outpatients
(but include day
cases)
Cholecystectomy
Procedure +
diagnosis
nts J18 main
Age <1, outpatients
(but include day
cases)
Restrict definition to
K80
Musculoskeletal disorders
Hip-replacement procedure
W37, W38,
W39,W46, W47,
W48, W93, W94,
W95
all
Age <1, outpatients
(but include day
cases)
Knee-replacement procedure W40,W41,W42 all
Age <1, outpatients
(but include day
cases)
Pregnancy and birth
Childbirth
diagnosis or
procedure (see
comment)
(Z37)
R17, R18, R19, R20,
R21, R22, R23, R24,
R25
secondary
Age <1, outpatients
(but include day
cases)
Aim to include all
births using relevant
diagnostic and/or
procedure codes.
Figure 1: Definitions of the ten treatments analysed
Definition of treatments and sample
Figure 1 shows the ten treatments analysed, and the definitions and codes we used to identify
eligible patients. We excluded patients treated in non-acute hospitals, those with missing cost data,
cost outliers (those with excessively high /low costs, defined as 3 standard deviations above or
below the mean) and patients treated in hospitals that cared for fewer than 5 patients having the
treatment in question. One hospital was excluded from the analyses because costs were reported
only for elective patients.
Data sources
Our primary data source was the Hospital Episode Statistics for 2007/8, which contains around 16.5
million observations. Each observation comprises a Finished Consultant Episode (FCE, hereafter
episode) which measures the time the patient spends under the care of a particular consultant.
Around 10% of patients are cared for by more than one consultant, most usually because they are
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transferred from one specialty to another. We can track the episodes pertaining to each individual
patient, allowing us to construct a provider spell for each patient, measuring the time from
admission to discharge. By linking successive episodes for each patient, we can take account of
diagnostic and other information in all of the records for those patients with multiple episodes.
Box 1: Mapping of Reference Cost to HES data
Source: Daidone and Street, 2011
We assigned a cost to every patient recorded in HES by using the Reference Cost reported by all
English hospitals. The mapping process is described in Box 1. This process is the same as that used in
the analysis of the costs of specialist care which has informed PbR (Daidone and Street, 2011).
Hospitals report their costs on the basis of episodes. For patients who have multiple episodes, we
calculate the cost of their spell as the highest cost episode. We purged reported costs of the
influence of geographical variation in input prices by dividing each patient cost by the relevant
hospital-level Market Forces Factor (MFF) (Department of Health, 2010).
Concerns have been raised about the accuracy of Reference Costs and, hence, about the accuracy of
patient-level costs assigned in this way. In view of these concerns, we also assessed whether results
were robust to using LoS as a measure of resource use. LoS has the advantage that it is defined in a
straightforward manner, calculated as the difference between the date of discharge and the date of
admission. The disadvantage is that LoS is an imperfect indicator of resource use, particularly for
surgical patients.
In their Reference Cost returns, hospitals report five pieces of cost information for each HRG (h=1H) in
each of their specialties (j=1J):
x Average cost per day case in HRG h: dhjkc
x Average cost for elective patients in HRG h with a length of stay below the HRG-specific
trimpoint value:
e
hjkc
x Excess per diem cost for an elective patient in HRG h who stays in hospital beyond the HRG-
specific trimpoint:
e
hjkex
x Average cost for non-elective (including maternity, baby or a transfer) patients in HRG h with a
length of stay below HRG-specific trimpoint value:
n
hjkc
x Excess per diem cost for a non-elective patient in HRG h who stays in hospital beyond the HRG-
specific trimpoint
n
hjkex
Trimpoints are defined for length of stay outliers in each HRG according to whether the patient was
admitted as an elective or non-elective. We define
e
h
t as the elective trimpoint in days and n
h
t as the
nonelective trimpoint for HRG h.
The costs provided by each hospital are assigned to each patient (i=1I) recorded in HES, according to
whether the patient was a day case ( )
d
a , elective ( )
e
a or non-elective ( )
n
a admission and how long
each patient stays in hospital, as follows:
x Day case: d dihjk hjkif a co
x Elective with length of stay at or below the elective trimpoint: ( , )e e eihj ihj h hjif a L t cd o
x Elective with length of stay above the elective trimpoint:
( , ) ( )
e e e e e
ihjk ihjk h hjk hjk ihjk hif a L t c ex L tª º! o  u ¬ ¼
x Non-elective with length of stay at or below the non-elective trimpoint:
( , )
n n
ihjk ihjk h hjkif a L t cd o
x Non-elective with length of stay above the non-elective trimpoint:
( , ) ( )e n n n n
ihjk ihjk h hjk hjk ihjk h
if a L t c ex L tª º! o  u ¬ ¼
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Analytic approach
Generally speaking, resource use varies among patients for two reasons: firstly because patients
have (very) different characteristics in regard to demographics, diagnoses and treatment, and,
secondly, because patients are treated in different hospitals. Our analysis is designed to identify the
source of variation, and to establish the influence of particular patient and hospital characteristics
on resource use. To do this, for each type of treatment we specified a multi-level model that
recognises that patients (level 1) are clustered within hospitals (level 2). With only two levels to the
hierarchy (patients clustered in hospitals), we can analyse variation in costs using a log-linear model
with fixed effects1:ݕ௜௞௖ ൌ ߚ଴ ൅ࢼᇱ࢞௜௞ ൅ࢼᇱᇱࢗ௜௞ ൅ ݑ௞ ൅ ߝ௜௞
where ࢟࢏࢑ࢉ is the (logarithmic) cost of patient i in hospital k, ݔ࢏࢑ is a vector of characteristics of
patient i in hospital k and ݍ࢏࢑ is a vector capturing measures of quality. For characteristics that
entered as dummy variables, their proportionate influence was calculated as ݌ ൌ ሾ(ߚ)െ ͳሿ
(Halvorsen and Palmquist, 1980). We assessed the statistical significance of coefficients at the 0.1%
level. The variables are summarised in Table 1. ݑ௞ captures the hospital influence on costs over and
above the patient characteristics while ߝ௜௞ is the standard disturbance.
The fixed effects, ݑ௞, can be interpreted as a measure of hospital performance, higher values
implying that this hospitals costs are above average after taking into account the characteristics of
the patients being treated (Hauck et al., 2003). However, the quality of care should be subject to
hospital influence. As such, it would not be legitimate to control for quality when comparing costs or
LoS across hospitals. Hence, the comparison of hospital costs was based on an equation that omits
quality, namely:ݕ௜௞௖ ൌ ߚ଴ ൅ࢼᇱ࢞௜௞ ൅ ݑ௞ ൅ ߝ௜௞
For each treatment type, we also estimated analogous models using LoS, ݕ௜௞௦ , as the dependent
variable. These are estimated as negative binomial (Negbin) models in recognition of the
distributional nature of LoS. Full details of the models applied are provided in Street et al., (2012).
We then considered the estimated hospital effects, ݑො௞, from the cost and LoS analyses. This allowed
us to explore reasons why some hospitals appear to have higher average costs or lengths of stay
than others. We included hospital characteristics as a vector of m variables in a regression of the
form:ݑො௞ ൌ ߛ଴ ൅ ࢽᇱࢠ௞ ൅ ߝ௞
We interpreted the hospital effects derived from the cost and LoS equations as measures of relative
hospital performance (Laudicella et al., 2010). These capture the average cost or LoS of the hospitals
patients, purged of the influence of the patient characteristics contained in the vector x in the first
stage equations.
Visual comparison of the effects across hospitals is instructive. We created graphs in which hospitals
were ordered (from left to right) from those with the lowest average effects to the highest. Patients
1
If our interest were solely in costs, a random effects model would be preferable, as it would allow consideration of both
patient-level and hospital-level characteristics in a single model. We adopted a fixed effects specification, though, in order
to ensure comparability with the LoS equations. Given our sample sizes, in practice the fixed and random effects are
virtually identical.
kz
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treated in hospitals to the left had lower costs or LoS than those in other hospitals (this not being
due to the characteristics of their patients). These hospitals seemed to be making better use of
resources than their counterparts.
Table 1: Variables used in the regression analyses
Type of variable Definition of variable Details
Stage 1
xvars Patient characteristics x age categories (based on quintiles)
x gender
x socio-economic status
x emergency admission dummy variable
x transfer in dummy variable
x transfer out dummy variable
x total number of diagnoses
x total number of procedures
x One non-severe Charlson comorbidity
x At least 1 severe or 2 non-severe Charlson comorbidities
x diagnosis of hypertension
x diagnosis of obesity
x Healthcare Resource Groups (HRGs)
x treatment type (diagnostic) variables
x treatment type (procedural) variables
x care by more than one consultant dummy variable (i.e. multiple
episodes)
qvars Quality variables x death
x at least one OECD surgical adverse event
x diagnosis of urinary tract infection
x wound infection
x diagnosis of C. difficile
Stage 2
zvars Hospital variables x Trust teaching status
x Trust total volume of spells /1000
x Trust percentage of treatment cases
x Trust weighted specialisation index
x Hospital adverse event indicator 1: % cases wound infection /UTI
x Hospital adverse event indicator 2: % cases surgical adverse
event
x Hospital adverse event indicator 3: % cases C. difficile
x Hospital adverse event indicator 4: % deaths
We also summarise the relative performance of hospitals across the set of treatments they provide.
This simply entails calculating their average rank across these treatments, after rescaling ranks to
take account of the number of hospitals providing each type of treatment.
All econometric analyses were run using Stata 11.1 (STATA Corporation, College Station, TX).
Explanatory variables
Stage 1: Patient-level variables
Demographic variables
Resource use may be related to the socio-demographic characteristics of the patient. We
constructed age categories based on quintiles chosen according to the observed distribution of age
for the treatment type, with the second age category forming the reference group. A dummy
variable was used to identify whether the patient was male. We also controlled for the income
deprivation of each patients local area, the rationale being that costs or LoS may be greater if timely
discharge is more difficult to arrange in more deprived areas. The index of multiple deprivation score
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provides the proportion of the patients local population living in households reliant on one or more
means-tested benefits (Noble et al., 2004).
Admission and clinical variables
We considered the impact on resource use of whether the patient was admitted as an emergency,
whether the patient was transferred from or to another institution or between consultants (i.e. had
multiple episodes) as part of their care pathway.
We accounted for the number of different diagnoses and procedures performed and we specified
various explanatory variables that are specific to the treatment in question which capture common
diagnostic characteristics and procedural techniques.
We also applied a form of the Charlson index (Charlson et al., 1987, Quan et al., 2005). We first
calculated a weighted global Charlson index score, by identifying the relevant ICD-10 codes recorded
as secondary diagnoses and by overweighting the 6 most severe among the 17 dimensions of
comorbidity proposed by Charlson.2 This calculation is adapted when necessary, if the diagnoses
included in the Charlson categories are directly related to the treatment analysed (in which case
they are not comorbidities). The disregarded comorbidities are:
x Myocardial infarction for analysis of AMI and CABG
x Cancer (any malignancy) and Metastatic solid tumor for Breast cancer
x Cerebrovascular disease and Hemiplegia/Paraplegia for stroke
We then defined three distinct patient groups based on their Charlson score: a dummy variable for
whether the patients suffer a single non-severe comorbidity (Charlson score=1); another dummy
variable indicates the patient was diagnosed with at least one severe or two non-severe
comorbidities (Charlson score>1); all other patients had no (Charlson) comorbidity (Charlson
score=0).
HRGs
We accounted for the HRG to which patients are allocated. HRGs were identified as dummy variables
when they included at least 1% of the sample for the treatment under consideration. These were
ordered and labelled so that the first dummy variable was the HRG with the lowest PbR tariff
(HRG1). As all patients were assigned to one HRG or another, in all specifications we omitted the
HRG to which the largest proportion of patients were allocated. This means that coefficients for all
variables can be interpreted in relation to this omitted reference HRG. A residual dummy variable
captured all other patients that were not assigned to the identified HRGs. There is substantial
variation in the number of HRG variables in the models depending on the type of treatment under
consideration: from 2 for stroke to 14 for hip replacement.
Quality variables
We also included a set of variables to capture the quality of care, the first of which indicates whether
the patient died in hospital.
Patient safety is a critical component of health care quality. The Agency for Healthcare Research and
Quality (AHRQ) and the University of California-Stanford Evidence-based practice Center developed
Patient Safety Indicators (PSIs) for use with hospital administrative data (Drösler et al., 2009, Quan et
2
The Hemiplegia/Paraplegia, Renal disease and Cancer (any malignancy) comorbidities are weighted by a coefficient
2, cases of Moderate or severe liver diseases by a coefficient 3, and Metastatic solid tumor and the AIDS/HIV cases
by a coefficient 6 (see Charlson et al., 1987 for details).
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al., 2008). We used the PSI 5 (Foreign body left in during procedure), 7 (Infection and inflammatory
reaction due to other vascular device, implant, etc), 12 (Pulmonary embolism/Deep vein
thrombosis), 13 (Sepsis) and 15 (Accidental cut, puncture, perforation, or haemorrhage during
medical care) and collapsed these into one dummy variable indicating the presence of an adverse
event. For childbirth, we used PSI 18 (Obstetric trauma) rather than the other indicators.
Finally, we defined three dummy variables that also can be considered measures of quality, namely
when urinary tract infection (UTI: ICD-10 codes N30.x, N39.0, O23.x and O86.2), post-operative
surgical infection (T81.4) or C. difficile (A047) are suffered during hospitalisation. Such events are a
sign of poor quality and might increase the cost and the duration of the hospital stay.
All of these quality variables are omitted from the model which is used for the analysis of the
hospital fixed effects because it is generally accepted that quality is within the hospitals control.
Stage 2: Hospital-level variables
Costs and LoS may vary among patients not merely because of their characteristics but also because
of the hospital in which they are treated. Our second-stage analysis is designed to explore the
explanatory power of various hospital characteristics, incorporated in the vector .
The characteristics considered include the hospitals teaching status; the amount and range of
activity undertaken; and the quality of care.
Teaching hospitals were identified using data from the Compendium of Clinical and Health Indicators
(The NHS Information Centre, 2009), which assigns hospitals to clusters including an acute
teaching cluster.
Hospitals might benefit from economies of scale, experiencing decreasing average costs as volume
increases. To examine this we included the number of patients (in thousands) treated in the hospital
and the proportion (in percent) of these having the treatment under consideration.
The range of activity offered by the hospital may also influence costs, and again it is difficult to
predict the direction of influence. We adapted a general definition of specialisation that describes
the concentration of activity across Major Diagnostic Categories (MDCs) in each hospital (Daidone
and D'Amico, 2009). As the HES data do not include MDCs, we used the HRG4 chapter to which
patients were assigned (A, B, C etc). The index ranges between 0 (the hospitals workload by HRG
chapter is distributed identically to that of the national average) and 1 (when all of a hospitals
activity is confined to a single HRG chapter).
Another reason that costs may differ among hospitals is that the quality of care differs. We
considered four adverse events indicators, estimated as the proportion of patients receiving a
treatment who experienced the adverse event. Indicator 1 is the rate of those experiencing either a
wound infection or UTI (or both). Indicator 2 is the rate of patients experiencing a PSI adverse event;
for childbirth, we use obstetric adverse events as a rate of those having childbirth. Indicator 3 is the
rate of patients with C. difficile, and indicator 4 is the death rate.
kz
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Table 2: Overview of the ten treatment types
Treatment type AMI Appendectomy Breast cancer CABG Child
birth
Cholecystectomy Hernia
(inguinal)
Hips Knees Stroke
N (patients) 72,807 32,927 30,025 18,875 549,036 43,917 64,155 82,902 62,034 69,372
N (hospitals) 150 151 139 28 144 148 151 151 147 149
No. HRG DVs 7 3 7 4 7 6 4 14 4 2
Length of stay (Los): mean (sd) 7.6
(9.0)
3.5
(3.0)
2.8
(2.7)
12.5
(11.1)
2.4
(2.2)
2.3
(3.8)
0.7
(1.7)
12.3
(14.2)
6.9
(5.7)
20.2
(24.4)
Log of cost: mean (sd) 7.4
(0.6)
7.6
(0.4)
7.5
(0.5)
8.9
(0.4)
7.3
(0.5)
7.5
(0.5)
7.0
(0.5)
8.6
(0.4)
8.3
(0.4)
7.8
(0.7)
Adjusted cost (£): mean (sd) £1,885
(£1,253)
£2,221
(£914)
£2,083
(£948)
£7,658
(£2,616)
£1,611
(£727)
£1,971
(£936)
£1,221
(£549)
£5,499
(£1,884)
£4,452
(£1,801)
£3,002
(£2,125)
Correlation: log of cost and LoS 0.25* 0.24* 0.50* 0.12* 0.43* 0.41* 0.35* 0.29* 0.10* 0.39*
Patient characteristics
age: mean (sd) 70.0
(14.1)
28.6
(17.2)
60.5
(12.6)
67.1
(9.8)
28.9
(6.1)
51.2
(16.2)
58.2
(18.1)
73.2
(12.2)
69.6
(9.5)
75.1
(13.6)
total no. diagnoses / patient: mean (sd) 5.1
(2.8)
1.7
(1.3)
2.3
(1.5)
6.6
(3.3)
3.2
(1.4)
2.3
(1.7)
1.9
(1.4)
4.1
(2.8)
3.1
(2.0)
5.7
(3.3)
total no. procedures / patient: mean (sd) 1.2
(1.6)
1.5
(1.0)
3.4
(1.1)
3.7
(2.3)
2.4
(1.2)
2.3
(0.9)
2.3
(0.7)
2.6
(1.2)
2.4
(0.9)
2.1
(1.7)
% males (n) 63.3%
(46,107)
55.6%
(18,304)
0.0%
(0)
78.7%
(14,848)
0.0%
(0)
23.5%
(10,303)
92.5%
(59,322)
33.9%
(28,074)
42.1%
(26,129)
47.5%
(32,982)
socioeconomic status (% living in area of income deprivation) (n) 16.3%
(11,872)
16.1%
(5,310)
14.2%
(4,265)
15.3%
(2,896)
19.3%
(106,135)
16.4%
(7,224)
14.7%
(9,416)
14.0%
(11,572)
14.6%
(9,036)
16.2%
(11,236)
% emergency admission (n) 87.3%
(63,585)
97.7%
(32,157)
0.3%
(91)
10.7%
(2,017)
0.4%
(2,455)
9.7%
(4,262)
4.2%
(2,704)
36.7%
(30,440)
0.8%
(508)
95.5%
(66,250)
% transferred in from other institution (n) 16.8%
(12,226)
4.1%
(1,348)
0.2%
(59)
25.3%
(4,781)
0.7%
(3,819)
0.6%
(248)
0.3%
(202)
3.2%
(2,629)
0.4%
(247)
8.4%
(5,843)
% transferred out to other institution (n) 21.1%
(15,379)
0.4%
(136)
0.4%
(113)
7.2%
(1,364)
0.6%
(3,171)
0.3%
(149)
0.3%
(166)
11.0%
(9,143)
2.4%
(1,489)
19.7%
(13,647)
% with one non-severe Charlson comorbidity (n) 27.4%
(19,974)
7.6%
(2,491)
11.4%
(3,427)
29.5%
(5,561)
3.2%
(17,800)
13.5%
(5,931)
10.5%
(6,764)
22.0%
(18,267)
20.1%
(12,439)
27.2%
(18,864)
% with >= 1 severe / 2 non-severe Charlson comorbidities (n) 20.9%
(15,227)
0.9%
(280)
1.7%
(509)
16.7%
(3,155)
0.1%
(455)
2.4%
(1,068)
2.7%
(1,743)
10.0%
(8,319)
5.0%
(3,071)
16.6%
(11,519)
% with hypertension (n) 39.8%
(28,994)
3.5%
(1,158)
19.7%
(5,925)
60.4%
(11,396)
0.0%
(132)
16.6%
(7,296)
16.3%
(10,471)
37.3%
(30,889)
41.8%
(25,908)
47.7%
(33,063)
% obese (n) 1.8% 0.4% 0.7% 4.3% 0.6% 2.2% 0.2% 1.4% 2.5% 0.7%
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Treatment type AMI Appendectomy Breast cancer CABG Child
birth
Cholecystectomy Hernia
(inguinal)
Hips Knees Stroke
(1,287) (128) (208) (805) (3,399) (967) (150) (1,164) (1,566) (469)
% treated by more than one consultant within stay (n) 47.1%
(34,313)
11.4%
(3,740)
0.8%
(244)
22.6%
(4,259)
4.3%
(23,663)
4.9%
(2,136)
1.2%
(780)
14.0%
(11,641)
3.0%
(1,842)
63.8%
(44,270)
% deaths (n) 10.1%
(7,381)
0.1%
(42)
0.0%
(7)
2.5%
(481)
0.0%
(10)
0.1%
(43)
0.1%
(58)
3.4%
(2,778)
0.2%
(135)
24.0%
(16,678)
% with at least one OECD adverse event (n) ** 1.4%
(1,046)
0.6%
(183)
0.1%
(26)
2.0%
(382)
2.0%
(11,078)
0.9%
(380)
0.1%
(79)
1.2%
(1,001)
0.9%
(547)
3.1%
(2,170)
% with urinary tract infection (n) 3.4%
(2,457)
0.5%
(163)
0.2%
(61)
1.3%
(242)
0.7%
(3,805)
0.2%
(95)
0.1%
(61)
3.6%
(2,953)
0.6%
(347)
9.0%
(6,251)
% with wound (post-op) infection (n) 0.1%
(62)
1.3%
(439)
0.2%
(67)
2.8%
(535)
0.0%
(13)
0.3%
(132)
0.0%
(32)
0.9%
(786)
0.2%
(155)
0.2%
(108)
% with C. difficile (n) 0.5%
(339)
0.0%
(15)
0.0%
(4)
0.4%
(77)
0.0%
(17)
0.0%
(20)
0.0%
(9)
0.7%
(606)
0.1%
(43)
1.8%
(1,262)
Hospital characteristics
% teaching hospitals 14.7% 14.6% 13.7% 64.3% 13.9% 14.9% 14.6% 14.6% 12.9% 14.8%
Total mean no. inpatients /yr ('000) 85.24 84.08 85.10 122.48 84.44 85.27 84.02 84.61 83.78 85.66
% treatment group cases 0.7% 0.3% 0.3% 1.2% 5.3% 0.4% 0.6% 0.9% 0.7% 0.6%
Hospital specialisation status (Gini index) *** 0.18 0.18 0.17 0.24 0.17 0.17 0.18 0.19 0.19 0.17
Hospital adverse event indicators
1: % cases w wound infection or UTI 4.0% 2.0% 0.6% 3.7% 0.7% 0.5% 0.1% 4.8% 0.9% 9.2%
2: % cases with OECD adverse event * 2.9% 1.7% 0.5% 2.6% 2.0% 0.5% 0.1% 3.7% 0.8% 5.6%
3: % cases with C. difficile 0.7% 0.1% 0.0% 0.4% 0.0% 0.1% 0.0% 0.8% 0.1% 1.9%
4: % deaths 11.2% 0.1% 0.0% 3.0% 0.0% 0.1% 0.1% 3.8% 0.3% 23.7%
Note: All LoS analyses were run using a negative binomial model because of the overdispersion in the dependent variable.
* Significant at 0.1% level
** in childbirth, an obstetrics adverse event variable was substituted in the first and second stage regressions.
***the Gini index is a continuous variable and ranges from 0 (non-specialised hospital) to 1 (fully specialised hospital).
Source: Hospital Episode Statistics 2007/8; Reference Costs 2007/8.
Abbreviations: DV: dummy variable; UTI: urinary tract infection; sd: standard deviation
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Results
Descriptive overview
We analysed patients admitted to hospital for one of ten types of treatment, summarised in Table 2.
The number of patients in each treatment group ranged from 18,875 (CABG) to 549,036 (childbirth),
and the number of hospitals contributing data ranged from 28 (also for CABG) to 151 (for
appendectomy, hernia and hip replacement).
CABG patients had the highest mean cost (£7,658), reflecting the complexity of their care. These
patients also had the highest mean number of diagnoses (6.6) and procedures (3.7) and were most
likely to have been transferred in from another institution (25.3%). CABG patients also had high
levels of comorbidity: almost 30% had one non-severe Charlson comorbidity, 17% had one severe (or
at least two non-severe) Charlson comorbidities (in addition to AMI), and over 60% had
hypertension. CABG patients were the most likely group of patients to suffer a post-operative
wound infection (2.8% on average).
Stroke patients had the longest stays (20.2 days) and were, on average, also the oldest patients in
our analysis (mean age: 75). They were also the most likely type of patient to have multiple
consultants overseeing their care (63.8% saw at least two consultants), most likely to die (24.0%), or
to suffer an adverse event (3.1%), urinary tract infection (UTI) (9.0%), or to contract C difficile (1.8%).
Patients undergoing an operation for inguinal hernia had both the lowest average LoS (0.73 days)
and lowest average cost (£1,221).
Women who had come to hospital to give birth had the lowest rates of comorbidity (both for non-
severe and severe Charlson categories, and for hypertension) and were the group of patients least
likely to die during their stay (0.002%) or to suffer wound infection (0.002%) or C difficile (0.003%).
The lowest rate of adverse events was among Breast Cancer and Hernia patients (0.1%).
Appendectomy patients were the youngest group (aged 28.6 on average) and were also the most
likely to be admitted as emergencies (97.7%). Women with breast cancer were the least likely to be
treated as emergency cases (0.3%) and also were the least likely to be transferred between
specialties during their hospital stay (0.8%).
When the characteristics of the hospitals are compared, some striking differences are apparent.
Although CABG patients were treated in a relatively small number of hospitals (28), most (64.3%) of
these were teaching hospitals. These were also the most specialised hospitals, with a mean
specialisation index of 0.24. For the remaining types of treatment, the index ranged between 0.17
and 0.19.
Regression results
The patient-level analyses explained between 32% (stroke) and 72% (breast cancer and knee
replacement) of the variation in cost. When LoS was the dependent variable, the corresponding
figures were 28% (stroke) and 63% (hip replacement).
Looking across the ten treatment types, a number of patterns are evident:
x Age: in general, older age was associated with higher cost and longer LoS.
x Gender: females were more costly and had longer stays than males, although the effect
was not always statistically significant.
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x Socioeconomic status: patients from more deprived areas sometimes had higher costs and
more frequently had longer stays.
x Transfers: patients who were transferred in to hospital were often costlier cases, but the
impact of transfers out on resource use was mixed.
x Total diagnoses: a higher total number of recorded diagnoses was associated with higher
cost and longer stay. This finding was consistent across all ten treatments.
x Total procedures: a higher total number of recorded operations was associated with higher
cost in most cases (9/10 treatments) and always with longer stay.
x Multiple episodes: the impact on cost was variable, but patients cared for by more than
one consultant typically had significantly longer stays.
x Quality: in most treatments, adverse events drove up LoS. Similarly where significant,
costs were higher.
Few of the hospital variables we tested proved to be significant explanators of cost or LoS. When
holding patient characteristics constant, the following hospital-level factors were found to be
significant:
x Hospital specialisation was a significant explanator for variations in the cost of
appendectomy. The more specialised the hospital  the fewer different types of activity
undertaken  the higher the average cost.
x The relative volume of hernia cases undertaken explained variations in stay. In hospitals
that undertook a larger proportion of hernia cases, average stay was significantly shorter.
x The higher the mortality rate amongst stroke patients, the longer was average LoS.
In none of the other seven treatments analysed was any hospital characteristic statistically
significant in explaining average cost or LoS.
The literature review identified a number of papers that analysed the predictors of cost and LoS for
each condition. These included randomised controlled trials, systematic reviews, and studies using
administrative patient data. Papers using bivariate and multivariate regression models with cost and
LoS as the variable of interest were especially relevant. Most of the studies identified age and
gender as being important drivers of variation in cost and LoS. Studies of appendectomy and
inguinal hernia in particular tended to focus on the differences in terms of cost and LoS between
open and laparoscopic approaches. Several studies found a positive relationship between the
number of diagnoses and procedures performed and cost and/or LoS. Similarly the number of
complications and poorer quality were generally found to be positively related to costs or LoS.
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Table 3: Overview of stage 1 (patient-level) regression results
Explanatory variable AMI
APPEND
-ECTOMY
BREAST
CANCER
CHILDBIRTH
CHOLE-
CYSTECTOMY
CABG HERNIA
HIP
REPLACEMENT
KNEE
REPLACEMENT
STROKE
Cost LoS Cost LoS Cost LoS Cost LoS Cost LoS Cost LoS Cost LoS Cost LoS Cost LoS Cost LoS
Age +/ns -/+ +/ns +/ns +/ns +/ns +/ns +/ns +/ns -/+ ns -/+ +/- +/- +/ns -/+ +/ns -/+ +/- +/-
Gender ns - ns - NA NA NA NA ns ns ns - - - ns - ns - ns -
Socioeconomic status ns + ns ns ns + + + + + ns + + + ns + ns + ns ns
Emergency admission DV + + + + ns + + + + + ns + + + + + ns + ns -
Transfer-in DV + ns + + ns ns + + ns ns + + ns + - ns ns + + +
Transfer-out DV - ns ns ns ns + - - ns + + + ns + + + + + + +
Total number diagnoses + + + + + + + + + + + + + + + + + + + +
Total number procedures + + + + + + + + + + + + + + + + ns + + +
1 non-severe Charlson comorbidity ns + ns - ns ns - - ns ns ns ns ns ns ns ns ns ns ns -
At least 1 severe / 2 non-severe
Charlson comorbidities
ns + ns ns ns ns ns + ns ns ns + ns ns ns ns ns ns - -
Hypertension comorbidity DV - - ns ns ns - ns ns ns ns - - - - - - ns - ns -
Obesity comorbidity DV - - ns ns ns ns ns - ns ns ns ns ns ns ns ns ns ns ns ns
HRGs +/ns -/ns -/+ +/ns +/- +/ns + + +/ns +/ns -/+/ns -/+/ns -/+ -/+ -/+/ns -/+ +/- +/-/ns -/ns ns
Treatment specific variables -/+/ns -/ns - +/ns -/+/ns -/+/ns +/ns +/- +/- +/- ns -/+/ns -/+/ns -/+/ns +/- +/ns +/ns +/ns +/- +/-/ns
Multiple episode DV + + - + ns + + + ns + - + + + - + ns + + +
Mortality DV - - ns ns ns ns ns ns ns ns ns - ns ns ns - ns ns - -
Adverse event DV + + ns ns ns ns + + ns ns + + ns ns ns + ns + + +
Infection: UTI + + ns ns ns + ns + ns ns ns + ns ns + + ns + + +
Wound infection ns + + + + + ns ns ns + + + ns + + + ns + ns ns
C. difficile + + ns + ns ns ns + ns ns ns + ns ns + + ns + + +
N 72793 72793 32927 32927 30025 30025 549036 549036 43917 43917 18875 18875 64155 64155 82902 82902 62034 62034 69372 69372
r2_a / adjusted deviance r^2 0.412 0.424 0.632 0.394 0.722 0.391 0.547 0.339 0.626 0.544 0.517 0.570 0.574 0.410 0.501 0.625 0.718 0.408 0.318 0.279
Key: DV: dummy variable; HRG: Healthcare Resource Group; UTI: urinary tract infection; ns: not significant; NA: not applicable.
Note: results are based on those from the fullmodels; significance assessed at the 0.1% level (***)
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Acute Myocardial Infarction (AMI)
Literature review
x Our searches found three studies looking at the drivers of cost among AMI patients.
x Bramkamp et al., (2007) used Switzerlands national multicenter registry, which included a
representative sample of 65 hospitals and 11,625 patient records, to investigate inpatient
costs of acute coronary syndromes (ACS).
o Their multivariate linear regression model found that older patients (>65) were more
costly than those under 65.
o They also found that the cost of treating female patients was 5% higher than male
patients.
x Dormont and Milcent, (2004) used data from 1994-1997 that included a sample of 7,314
patients in 36 public hospitals to investigate the drivers of hospital costs for AMI in France.
o The authors used natural costs as the dependent variable and conditioned on LoS by
including it as an explanatory variable in their analysis.
o They found that males were more costly than females and that cost was a
decreasing function of age. While this result may seem counterintuitive, the authors
suggest this is probably due to older people having undergone fewer procedures.
x As part of the EuroDRG project, researchers from 10 countries sought to explain the
determinants of cost and LoS across Europe using individual level data from their country
(Peltola et al., 2012).
o In 7/10 countries, older patients had longer lengths of stay or higher costs.
o A higher number of diagnoses significantly increased both cost and LoS.
o More procedures and the use of PTCA (Percutaneous transluminal coronary
angioplasty) or stent significantly increased cost in most countries.
o Mortality was associated with significantly lower cost or LoS in almost all countries.
Patient-level analysis
Results of our analysis of the costs and LoS for the 72,807 patients treated in 150 hospitals for AMI
are presented in Table 4. The table reports summary statistics followed by four sets of regression
results. For the first two sets, costs are the dependent variable, the full model including all patient-
level variables and the partial model omitting measures of quality. The second two sets of results
analyse LoS as the dependent variable. In Box 2 below, we highlight those variables that are
significant (P<0.001) explanators of cost or LoS.
Box 2: Variables that are significant explanators of cost or LOS for AMI
Variables Our Findings
Dependent
variables (mean)
Cost  £1,885
LoS  7.6
Demographics Cost and LoS generally increased with patient age.
LoS was also longer among female patients and patients living in poorer areas.
Admission/
Discharge
Emergency admissions were 7% more costly and LoS is 37% longer than electives.
Patients transferred in had 13% higher costs while patients transferred out were 6% cheaper.
The impact of transfers on patient LoS was insignificant when quality indicators were included. When quality was excluded,
patients transferred in had 7% shorter spells while those transferred out stayed 6% longer.
Patients treated by more than one consultant had significantly longer LoS and higher costs.
Case
Complexity
Patients undergoing more procedures or with more diagnoses had higher costs and LoS.
LoS was also higher among patients diagnosed with Charlson comorbidities, by 5% for non-severe comorbidities and 13% for
major comorbidities. However, a diagnosis of hypertension or obesity was associated with 4% lower cost and shorter LoS for
hypertension (13%) and obesity (9%).
HRGs Relative to the base HRG case actual or suspected AMI (EB10Z), costs were highest, increasing by 45%-60%, when
revascularisation procedures involved stenting (EA31Z, EA32Z and EA33Z). The broader Other non-complex cardiac surgery with
catheterisation (EA41Z) was associated with 19% higher costs, while catheterisation used alone in patients under 19 (EA36Z)
cost 41% more than the reference group. The use of catheterisation and stents generally reduced patient LoS.
Treatment
Specific
Patients diagnosed with a subsequent AMI had a 3% lower cost and 9% shorter LoS.
A small proportion of patients were treated with stents (15%) or a PTCA procedure (1%). These patients had 24% shorter and 22%
shorter LoS respectively. However, where a PTCA procedure was used, costs were 13% higher. The shorter LoS of these patients
who were given a stent or PTCA may in part be due to their levels of comorbidity, which were significantly lower than those of
other patients (Figure 2). ST elevated AMI cases had lower cost and LoS while non ST elevated cases had higher cost and LoS.
However, the impact of these variables was only significant when no adjustment was made for the quality of patient care.
Quality Patients who experienced an adverse event, or infection, had longer LoS and higher costs.
Around 10% of patients died whilst in hospital. These patients had 19% lower costs and 34% shorter LoS.
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Table 4: Cost and LoS in AMI: patient-level analysis
Log of cost LoS #
Explanatory variable mean sd Full Model Partial Model Full Model Partial Model
ɴ se ɴ se ɴ se ɴ se
Age 1: <59 0.224 0.417 -0.015** 0.005 -0.013** 0.005 0.887*** 0.008 0.887*** 0.008
Age 2: 59-69 0.227 0.419 ref ref ref ref ref ref ref ref
Age 3: 70-77 0.196 0.397 0.022*** 0.005 0.017** 0.005 1.141*** 0.011 1.142*** 0.012
Age 4: 78-84 0.188 0.391 0.052*** 0.005 0.045*** 0.006 1.272*** 0.013 1.277*** 0.013
Age 5: 85+ 0.165 0.371 0.099*** 0.006 0.083*** 0.007 1.497*** 0.018 1.497*** 0.018
Gender 0.633 0.482 -0.005 0.004 -0.008* 0.004 0.957*** 0.007 0.944*** 0.007
Socioeconomic status 0.163 0.122 0.018 0.015 0.021 0.016 1.135*** 0.034 1.166*** 0.036
Emergency admission DV 0.873 0.333 0.064*** 0.011 0.098*** 0.011 1.367*** 0.027 1.478*** 0.03
Transfer-in DV 0.168 0.374 0.125*** 0.01 0.101*** 0.01 0.984 0.017 0.927*** 0.016
Transfer-out DV 0.211 0.408 -0.062*** 0.005 -0.051*** 0.005 1.016 0.01 1.057*** 0.011
Total number diagnoses 5.124 2.829 0.029*** 0.001 0.037*** 0.001 1.095*** 0.002 1.117*** 0.002
Total number procedures 1.181 1.582 0.052*** 0.002 0.060*** 0.002 1.148*** 0.004 1.156*** 0.004
One non-severe Charlson comorbidity 0.274 0.446 0.001 0.004 -0.012** 0.004 1.049*** 0.009 1.023** 0.008
At least 1 severe or 2 non-severe Charlson comorbidities 0.209 0.407 0.013* 0.006 -0.016** 0.006 1.125*** 0.012 1.065*** 0.012
Hypertension comorbidity DV 0.398 0.490 -0.036*** 0.004 -0.036*** 0.004 0.872*** 0.006 0.860*** 0.006
Obesity comorbidity DV 0.018 0.132 -0.037*** 0.011 -0.036** 0.011 0.913*** 0.021 0.907*** 0.02
HRG1: EB10Z DV; Actual or Suspected MI 0.677 0.468 ref ref ref ref ref ref ref ref
HRG2: AB06Z DV; Minor pain procedures 0.031 0.174 -0.007 0.013 -0.044** 0.014 0.919*** 0.015 0.849*** 0.015
HRG3: EA36Z DV; Catheter 19 Years+ 0.094 0.292 0.344*** 0.007 0.359*** 0.007 0.968* 0.013 1.001 0.013
HRG4: EA41Z DV; Other non-complex Cardiac Surgery with Catheterisation 0.020 0.140 0.177*** 0.015 0.171*** 0.016 0.777*** 0.022 0.778*** 0.021
HRG5: EA31Z DV; PCI with 0-2 Stents 0.103 0.304 0.369*** 0.015 0.399*** 0.009 0.939** 0.023 0.719*** 0.011
HRG6: EA32Z DV; PCI with 0-2 stents and Catheterisation 0.031 0.173 0.439*** 0.016 0.443*** 0.012 0.875*** 0.025 0.651*** 0.015
HRG7: EA33Z DV; PCI 3 with Stents 0.011 0.103 0.470*** 0.02 0.494*** 0.017 0.990 0.036 0.764*** 0.025
HRG8: Other non-reference HRG DV 0.033 0.180 0.315*** 0.016 0.274*** 0.017 0.909*** 0.019 0.829*** 0.019
ST elevated MI 0.296 0.456 -0.007 0.005 -0.019*** 0.005 0.978** 0.008 0.949*** 0.008
Non-ST-elevated 0.114 0.318 0.014* 0.007 0.035*** 0.007 1.031* 0.013 1.051*** 0.014
Subsequent MI 0.177 0.382 -0.028*** 0.005 -0.027*** 0.005 0.910*** 0.009 0.897*** 0.008
Insertion of Stent into Coronary Artery 0.155 0.362 0.032* 0.014 0.765*** 0.018
PTCA in Episode DV 0.010 0.100 0.126*** 0.024 0.782*** 0.03
Multiple episode DV 0.471 0.499 0.186*** 0.004 1.511*** 0.012
Mortality DV 0.101 0.302 -0.216*** 0.008 0.658*** 0.01
Adverse event DV 0.014 0.119 0.097*** 0.018 1.318*** 0.037
Infection DV: UTI 0.034 0.181 0.145*** 0.011 1.406*** 0.027
Infection DV: post-operative infection 0.001 0.029 0.201** 0.068 1.456*** 0.164
Infection DV: C difficile 0.005 0.068 0.466*** 0.037 2.331*** 0.102
Constant 6.891*** 0.013 6.906*** 0.013 2.153*** 0.052 2.271*** 0.055
alpha 0.386*** 0.004 0.443*** 0.004
N 72793 72793 72793 72793
r2_a / adjusted deviance r^2 0.447 0.412 0.479 0.424
# Exponentiated coefficients; DV: dummy variable; HRG; healthcare resource group; PCI: Percutaneous coronary intervention; UTI: urinary tract infection. * p < 0.05, ** p < 0.01, *** p < 0.001
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Figure 2: Relationship between comorbidity (Charlson score), PTCA and Stenting: AMI patients
Note: the figures compare the levels of comorbidity in treated and untreated patients. Comorbidity is assessed using the Charlson index:
this is scaled as 0 (no Charlson comorbidity), 1 (one non-severe Charlson comorbidity), or 2 (at least one severe, or more than one non-
severe, Charlson comorbidity). Only 1% of the 72,793 patients with AMI (n=735) received a PTCA, and 15% (11,270) received a stent. For
both stents and PTCAs, patients who did not receive the procedure were sicker than those who were treated.
Hospital performance
Care for AMI patients in England was provided in 150 hospitals. Figure 3 plots the hospital fixed
effects from the cost and LoS equations, once the differences in patient characteristics (other than
quality) are controlled for. Hospitals are ranked by their deviation from the average (national) cost
or LoS. Hospitals on the left hand-side have lower costs (LoS) than the average, while those on the
right hand-side have higher costs (LoS). We see that, even after controlling for measurable
characteristics of patients, large variations in the average cost or LoS of AMI patients across hospitals
persisted. Average costs varied from 16% below to 10% above the national average while average
LoS varied from 54% below to 57% above the national average. However we did not identify any
specific characteristics of hospitals that had a significant influence on their average costs or LoS.
Figure 3: Hospital fixed effects: AMI
Hospitals at both extremes of the two distributions are identified below. Judgements about the
relative performance of some hospitals depend on whether costs or LoS are examined. For instance,
AMI patients treated at the Royal Brompton & Harefield NHS Trust and The Cardiothoracic Centre -
Liverpool NHS Trust had the lowest LoS nationally but this did not translate directly into lower costs.
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In other hospitals, both the average cost and LoS were among the lowest nationally, notably
Worthing & Southlands Hospitals NHS Trust, George Eliot Hospital NHS Trust, and North Hampshire
Hospitals NHS Trust. At the other extreme, some hospitals had both high costs and LoS, namely
Royal United Hospital Bath NHS Trust, Swindon & Marlborough NHS Trust, and Trafford Healthcare
NHS Trust.
Overall, the rank correlation between each hospitals average cost and LoS was r=0.25 (P=0.0017)
indicating a small, but significant, positive relationship between hospital average cost and LoS for
AMI.
Box 3: Hospitals in top/bottom 5% by rank: AMI
cost
rank
LoS
rank
Hospital Name LoS
rank
cost
rank
Hospital Name
1 50 Southend University Hospital NHS
Foundation Trust
1 55 Royal Brompton & Harefield NHS Trust
2 48 Salisbury NHS Foundation Trust 2 138 The Cardiothoracic Centre - Liverpool NHS Trust
3 18 North Cheshire Hospitals NHS Trust 3 29 Papworth Hospital NHS Foundation Trust
4 6 Worthing & Southlands Hospitals NHS Trust 4 7 North Hampshire Hospitals NHS Trust
5 8 George Eliot Hospital NHS Trust 5 65 University College London Hospitals NHS
Foundation Trust
6 93 South Warwickshire General Hospitals NHS
Trust
6 4 Worthing & Southlands Hospitals NHS Trust
7 4 North Hampshire Hospitals NHS Trust 7 101 Ealing Hospital NHS Trust
8 102 Lancashire Teaching Hospitals NHS
Foundation Trust
8 5 George Eliot Hospital NHS Trust
143 15 Bradford Teaching Hospitals NHS Foundation
Trust
143 96 Surrey & Sussex Healthcare NHS Trust
144 144 Swindon &Marlborough NHS Trust 144 144 Swindon &Marlborough NHS Trust
145 140 Royal United Hospital Bath NHS Trust 145 82 City Hospitals Sunderland NHS Foundation Trust
146 113 Wrightington, Wigan & Leigh NHS Trust 146 136 Mid Yorkshire Hospitals NHS Trust
147 98 Heatherwood &Wexham Park Hospitals NHS
Trust
147 140 Trafford Healthcare NHS Trust
148 133 West Middlesex University Hospital NHS
Trust
148 94 Essex Rivers Healthcare NHS Trust
149 11 Royal Devon & Exeter NHS Foundation Trust 149 93 Tameside & Glossop Acute Services NHS Trust
150 25 Southampton University Hospitals NHS Trust 150 44 Weston Area Health NHS Trust
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Appendectomy
Literature review
x Much other research has concentrated on determining the cost and LoS impact of
laparoscopic appendectomy (LA) relative to open appendectomy (OA).
x Sporn et al., (2009) performed a retrospective analysis of data from an annual survey of
U.S. community based hospitals for the years 2000 to 2005.
o Patients were stratified into those with complicated appendectomy and those
without.
o After controlling for age, gender, ethnicity and a number of comorbidities, LoS for LA
was found to be 15% shorter than OA in both complicated and uncomplicated cases.
o Costs for LA were 22% higher in uncomplicated cases and 9% higher for complicated
cases.
x Sauerland et al., (2010) conducted a Cochrane systematic review of the diagnostic and
therapeutic effects of LA and OA.
o Sixty seven studies were included of which 56 compared LA to OA in adults. They
found that length of hospital stay was shorter for those undergoing LA by 1.1 day.
x Tsai et al., (2008) used a retrospective study to analyse diabetic and non-diabetic patients
who acquired acute appendicitis in a single institution over a 5 year period.
o Those diagnosed with diabetes had a longer hospital stay compared to non-diabetic
patients.
x As part of the EuroDRG project, researchers analysed cost and LoS for the treatment of
appendectomy across 10 European countries (Mason et al., 2012).
o They found a U-shaped relationship between age and LoS with younger (<11) and
older (>35) age groups tending to have longer stays.
o A higher number of diagnosis and procedures significantly increased costs and LoS.
o Where significant, emergency cases tended to have longer stays and higher costs.
Patient-level analysis
Full results of our analysis of the costs and LoS for the 32,927 patients treated in 151 hospitals for
appendectomy are presented in Table 5. Following the summary statistics, we estimate from the
analyses of cost and LoS applying both the full and partial models. Variables that are significant
(P<0.001) explanators of cost or LoS are summarised in Box 4 below.
Box 4: Variables that are significant explanators of cost or LOS for Appendectomy
Variables Our Findings
Dependent
variables (mean)
Cost  £2,221
LoS  3.5
Demographics Patients aged 14 and under had significantly higher costs and longer LoS than those aged 15 to 20.
LoS was longer among patients over 29 and in female patients.
Admission/
Discharge
Patients transferred in from another hospital and emergency cases had higher costs and longer LoS
(see Figure 4).
Emergency patients had 42% higher costs and 79% longer LoS, suggesting a marked difference to the
2% of elective appendectomy patients.
Patients transferred between consultants stayed 10% longer but cost 2% less than those under the
care of a single consultant throughout their hospital stay.
Case
Complexity
Patients diagnosed with a larger number of conditions had higher cost and LoS. Cases involving more
procedures were also associated with higher cost and LoS.
However, patients diagnosed with a single, non-severe, Charlson comorbidity had 7% shorter LoS.
HRGs Relative to the reference HRG of Appendectomy in over 18s without complications (FZ20B),
patients aged under 18 (FZ20C) had 8% lower costs.
Of adult patients, those who suffered from complications (FZ20A) had 30% higher costs and 23%
longer LoS compared with the reference group.
Treatment
Specific
Patients who underwent a laparoscopic procedure had lower costs, even if this approach failed.
If a laparoscopic procedure was successful, patient LoS was 23% shorter.
Quality Patients who suffered from a post operative infection had 13% higher costs and 46% longer LoS,
while LoS was over twice as long in the small proportion (<0.1%) of cases with C. difficile.
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Table 5: Cost and LoS in appendectomy: patient-level analysis
Log of cost LoS #
Explanatory variable mean sd Full Model Partial Model Full Model Partial Model
ɴ se ɴ se ɴ se ɴ se
Age 1: 1 to 14 0.219 0.414 0.022
***
0.005 0.028
***
0.005 1.122
***
0.013 1.162
***
0.013
Age 2: 15 to 20 0.197 0.398 ref ref ref ref ref ref ref ref
Age 3: 21 to 29 0.199 0.399 -0.018
**
0.005 -0.019
***
0.006 0.994 0.015 0.992 0.015
Age 4: 30 to 43 0.192 0.394 -0.012
*
0.006 -0.013
*
0.006 1.082
***
0.016 1.086
***
0.017
Age 5: 44+ 0.193 0.395 0.005 0.006 0.007 0.006 1.331
***
0.021 1.363
***
0.022
Gender 0.556 0.497 -0.002 0.003 0.004 0.003 0.932
***
0.007 0.967
***
0.007
Socioeconomic status 0.161 0.124 -0.009 0.012 -0.01 0.012 1.066
*
0.032 1.067
*
0.033
Emergency admission DV 0.977 0.151 0.350
***
0.02 0.356
***
0.02 1.787
***
0.061 1.905
***
0.067
Transfer-in DV 0.041 0.198 0.095
***
0.012 0.096
***
0.012 1.130
***
0.025 1.140
***
0.026
Transfer-out DV 0.004 0.064 0.048 0.034 0.05 0.034 1.251
*
0.11 1.248
**
0.105
Total number diagnoses 1.688 1.264 0.015
***
0.002 0.018
***
0.002 1.103
***
0.005 1.132
***
0.005
Total number procedures 1.547 0.994 0.025
***
0.003 0.020
***
0.002 1.145
***
0.006 1.122
***
0.005
One non-severe Charlson comorbidity 0.076 0.264 -0.015
*
0.006 -0.019
***
0.006 0.932
***
0.014 0.898
***
0.014
At least 1 severe or 2 non-severe Charlson comorbidities 0.009 0.092 -0.014 0.02 -0.025 0.02 0.891
*
0.044 0.823
***
0.04
Hypertension comorbidity DV 0.035 0.184 -0.003 0.009 -0.008 0.009 1.018 0.025 0.982 0.024
Obesity comorbidity 0.004 0.062 -0.005 0.022 -0.006 0.022 0.895
*
0.049 0.871
*
0.048
HRG1: FZ20B DV; appendectomy >18 w/o mcc 0.579 0.494 ref ref ref ref ref ref ref ref
HRG2: FZ20C DV; appendectomy <18 0.349 0.477 -0.073
***
0.006 -0.072
***
0.006 1.003 0.016 1.01 0.016
HRG3: FZ20A DV; appendectomy >18 w mcc 0.040 0.196 0.262
***
0.011 0.289
***
0.01 1.233
***
0.029 1.360
***
0.03
HRG4: Other non-reference HRG DV 0.032 0.175 0.286
***
0.018 0.298
***
0.018 1.222
***
0.029 1.347
***
0.032
Laparoscopy DV 0.239 0.426 -0.039
***
0.004 0.773
***
0.008
Failed laparoscopy DV 0.033 0.178 -0.029
***
0.008 1.048
**
0.019
Multiple episode DV 0.114 0.317 -0.025
***
0.005 1.096
***
0.014
Mortality DV 0.001 0.036 0.009 0.048 0.789 0.099
Adverse event DV 0.006 0.074 0.071
*
0.03 1.108
*
0.054
Infection DV: UTI 0.005 0.070 0.026 0.02 1.102 0.07
Infection DV: post-operative infection 0.013 0.115 0.119
***
0.019 1.460
***
0.043
Infection DV: C difficile 0.000 0.021 0.217
*
0.105 2.518
***
0.395
Constant 7.239
***
0.021 7.218
***
0.021 1.228
***
0.046 1.056 0.041
alpha 0.063*** 0.004 0.073*** 0.004
N 32927 32927 32927 32927
r2_a / adjusted deviance r^2 0.635 0.632 0.423 0.394
# Exponentiated coefficients; DV: dummy variable; w: with; w/o: without; cc: complications and comorbidities; icc: intermediate cc; mcc: major cc; UTI: urinary tract infection.
* p < 0.05, ** p < 0.01, *** p < 0.001
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Figure 4: Variation in LoS by admission type: appendectomy
Note: Box plot shows, from top to bottom: outside values (dots), upper adjacent value, 75
th
percentile (upper hinge),
median, 25
th
percentile (lower hinge) and lower adjacent value.
Hospital performance
After adjusting for casemix differences, the variation in average hospital costs for appendectomy
was not substantial, ranging from 11% below to 11% above the national average. In contrast, the
average LoS varied from 40% below to 49% above the national average. In the stage 2 analysis, we
found that the more the hospital concentrates on a limited range of activities, the higher the
average costs of treating appendectomy patients. No other variable was significant.
Figure 5: Hospital fixed effects: appendectomy
In the cost graph in Figure 5, one middle-ranking hospital  Gloucestershire Hospitals NHS
Foundation Trust  has a wide confidence interval around its mean value. This reflects a bimodal
cost distribution in the raw patient-level cost data for this hospital, which was not explained by the
casemix variables in our model. In the LoS graph, the same hospital appears on the right-hand side,
indicating substantial uncertainty around the mean value. This arises because a small proportion of
patients had long stays, which the patient-level characteristics did not explain.
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Overall, the relationship between each hospitals average costs and LoS was weak; the correlation
was very small and not statistically significant (r=0.09; P=0.2698). As a consequence, each hospitals
relative rank is sensitive to the choice of resource use measure, with only the Royal West Sussex NHS
Trust among the top 5% on both measures. In both cost and LoS rankings, Birmingham Children's
Hospital NHS Foundation Trust appears in the bottom 5%.
Box 5: Hospitals in top/bottom 5% by rank: Appendectomy
cost
rank
LoS
rank
Hospital Name LoS
rank
cost
rank
Hospital Name
1 129 Sherwood Forest Hospitals NHS
Foundation Trust
1 132 West Suffolk Hospitals NHS Trust
2 149 The Royal Wolverhampton Hospitals NHS
Trust
2 30 Heatherwood &Wexham Park
Hospitals NHS Trust
3 52 North Tees & Hartlepool NHS Trust 3 123 Frimley Park Hospital NHS
Foundation Trust
4 136 Bedford Hospital NHS Trust 4 6 Royal West Sussex NHS Trust
5 108 Sandwell & West Birmingham Hospitals
NHS Trust
5 85 Winchester & Eastleigh Healthcare
NHS Trust
6 4 Royal West Sussex NHS Trust 6 25 Yeovil District Hospital NHS
Foundation Trust
7 40 Kingston Hospital NHS Trust 7 120 Plymouth Hospitals NHS Trust
8 135 University Hospitals of Morecambe Bay
NHS Trust
8 24 Maidstone & Tunbridge Wells NHS
Trust
144 151 Birmingham Children's Hospital NHS
Foundation Trust
144 117 Sheffield Teaching Hospitals NHS
Foundation Trust
145 25 Doncaster & Bassetlaw Hospitals NHS
Foundation Trust
145 39 Northern Lincolnshire & Goole
Hospitals NHS Trust
146 32 York Hospitals NHS Foundation Trust 146 40 South Warwickshire General
Hospitals NHS Trust
147 132 Great Ormond Street Hospital For
Children NHS Trust
147 84 Aintree University Hospitals NHS
Foundation Trust
148 74 Blackpool, Fylde &Wyre Hospitals NHS
Trust
148 64 Gloucestershire Hospitals NHS
Foundation Trust
149 116 Southport and Ormskirk Hospital NHS
Trust
149 2 The Royal Wolverhampton Hospitals
NHS Trust
150 126 Scarborough and North East Yorkshire
Health Care NHS Trust
150 127 United Bristol Healthcare NHS Trust
151 118 Leeds Teaching Hospitals NHS Trust 151 144 Birmingham Children's Hospital NHS
Foundation Trust
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Breast cancer
Literature Review
x Downing et al., (2009) identified the predictors of LoS for breast cancer patients in two
regions of England over the period 1997/98 to 2004/05.
o A multi-level model with patients clustered within surgical teams and NHS Trusts was
used to examine associations between LoS and a range of factors.
o Older age, advanced stage breast cancer at time of diagnosis, presence of
comorbidities, lymph node excision and reconstructive surgery were associated with
increased LoS.
o The study identified significant unexplained variation in LoS amongst Trusts and
surgical teams.
x Participants of the EuroDRG project used the same methodology as this CHE Research
Paper to predict the impact of DRGs and a series of patient characteristics on cost and LoS
for breast cancer in 10 countries (Scheller-Kreinsen et al., 2012).
o Compared to those aged 51-69, those over 70 had significantly higher costs and LoS
while those aged less than 50 had shorter stays.
o Having a higher number of procedures significantly increased cost and LoS in all
countries, while a higher number of diagnoses followed a similar pattern in seven
countries.
o Postoperative wound infection increased costs and LoS in most countries.
o Patients with a main diagnosis of carcinoma in situ of breast tended to have
significantly lower costs and LoS while having a plastic operation had the opposite
effect  increasing both cost and LoS.
o Patients who received a total mastectomy had significantly higher costs and LoS.
Patient-level analysis
We analysed the costs and LoS of 30,025 women with breast cancer who were treated in 139
hospitals. Detailed results are provided in Table 6. In Box 6 below, we summarise variables that are
significant (P<0.001) explanators of variations in patient cost or LoS.
Box 6: Variables that are significant explanators of cost or LOS for breast cancer
Variables Our Findings
Dependent
variables (mean)
Cost  £2,083
LoS  7.5
Demographics Patients aged over 71 had higher costs than those aged between 50 and 57 while LoS
increased with age among patients over 64.
LoS was also longer among patients living in poorer areas.
Admission/
Discharge
Although they constituted less than 0.5% of the total sample, emergency cases and those
ending in a transfer to another hospital had over 50% longer LoS. Patients treated by more
than one consultant typically had longer LoS.
Case
Complexity
A higher number of diagnoses or procedures was associated with increased cost and LoS.
However, LoS was 8% shorter when hypertension was diagnosed.
HRGs The impact on cost and LoS of patient HRG was frequently significantly different from the
reference HRG Major breast procedure category 3 (JA06Z), with coefficients rising
broadly in line with the tariff. Figure 6 shows how cost (in natural units) varied by HRG.
Treatment
Specific
Patients diagnosed with a carcinoma in situ of breast had 3% lower cost and 8% shorter
LoS.
Cost and LoS were higher if patients underwent lymph node resection, plastic operation on
breast or total mastectomy.
The impacts of Malignant neoplasm of breast and Secondary and unspecified malignant
neoplasm of lymph node on cost and LoS were sensitive to whether or not quality was
accounted for.
Quality In the 0.2% of cases where post operative infection occurred, patient cost was 17% higher
and LoS 93% longer.
Patient LoS also increased if diagnosed with a UTI, by 60% and 34% respectively.
24 CHE Research Paper 78
Table 6: Cost and LoS in breast cancer patients: patient-level analysis
Log of cost LoS #
Explanatory variable mean sd Full Model Partial Model Full Model Partial Model
ɴ se ɴ se ɴ se ɴ se
Age 1: 1 to 49 0.198 0.399 0.000 0.005 0.008 0.005 0.994 0.012 1.038
**
0.014
Age 2: 50 to 57 0.203 0.403 ref ref ref ref ref ref ref ref
Age 3: 58 to 64 0.220 0.414 0.002 0.004 0.003 0.005 1.033
**
0.012 1.040
**
0.014
Age 4: 65 to 71 0.187 0.390 0.007 0.005 0.008 0.005 1.087
***
0.013 1.101
***
0.016
Age 5: 72+ 0.191 0.393 0.023
***
0.005 0.041
***
0.005 1.275
***
0.016 1.448
***
0.020
Gender 0.000 0.000 omitted omitted omitted omitted
Socioeconomic status 0.142 0.111 0.018 0.014 0.015 0.014 1.188
***
0.044 1.167
***
0.048
Emergency admission DV 0.003 0.055 0.138
*
0.064 0.138
*
0.064 1.777
***
0.196 1.930
***
0.214
Transfer-in DV 0.002 0.044 0.060 0.046 0.060 0.046 1.113 0.137 1.106 0.126
Transfer-out DV 0.004 0.061 0.052 0.027 0.069
**
0.027 1.562
***
0.173 1.774
***
0.190
Total number diagnoses 2.258 1.538 0.007
***
0.002 0.011
***
0.002 1.064
***
0.005 1.098
***
0.005
Total number procedures 3.360 1.103 0.020
***
0.002 0.025
***
0.002 1.091
***
0.005 1.093
***
0.005
One non-severe Charlson comorbidity 0.114 0.318 0.000 0.005 -0.003 0.005 1.002 0.014 0.981 0.015
At least 1 severe or 2 non-severe Charlson comorbidities 0.017 0.129 -0.010 0.012 -0.014 0.012 1.013 0.035 1.010 0.035
Hypertension comorbidity DV 0.197 0.398 -0.002 0.004 -0.007 0.004 0.923
***
0.012 0.890
***
0.013
Obesity comorbidity DV 0.007 0.083 -0.006 0.014 -0.009 0.015 0.994 0.047 0.984 0.052
HRG1: JA09B DV; Intermediate Breast Proc w/o cc 0.126 0.332 -0.580
***
0.008 -0.670
***
0.006 0.697
***
0.014 0.455
***
0.008
HRG2: JA09A DV; Intermediate Breast Proc w cc 0.078 0.268 -0.478
***
0.008 -0.570
***
0.006 0.814
***
0.017 0.529
***
0.011
HRG3: JA07B DV; Major Breast Proc cat2 w icc 0.166 0.372 -0.227
***
0.006 -0.295
***
0.004 0.847
***
0.013 0.624
***
0.009
HRG4: JA06Z DV; Major Breast Proc cat3 0.303 0.459 ref ref ref ref ref ref ref ref
HRG5: JA07C DV; Major Breast Proc cat2 w/o cc 0.271 0.445 -0.333
***
0.006 -0.401
***
0.004 0.752
***
0.012 0.556
***
0.008
HRG6: JA07A DV; Major Breast Proc cat2 wmcc 0.013 0.113 -0.106
***
0.016 -0.163
***
0.016 0.990 0.047 0.782
***
0.040
HRG7: JA05Z DV; Pedicled Myocutaneous Breast Recon w/o Prosthesis 0.023 0.150 0.290
***
0.018 0.410
***
0.015 1.073
**
0.029 1.606
***
0.032
HRG8: Other non-reference HRG DV 0.021 0.142 -0.345
***
0.022 -0.389
***
0.024 0.903
**
0.031 0.803
***
0.030
Carcinoma in situ of breast 0.122 0.327 -0.032
***
0.006 -0.033
***
0.006 0.919
***
0.013 0.932
***
0.016
Malignant neoplasm of breast 0.007 0.081 -0.010 0.016 0.020 0.016 0.970 0.044 1.174
***
0.054
Secondary and unspecified malignant neoplasm of lymph nodes 0.162 0.369 0.002 0.004 0.015
***
0.004 0.965
**
0.011 1.025
*
0.012
Metastasis 0.005 0.073 -0.030 0.023 -0.018 0.023 1.075 0.076 1.107 0.075
Lymph node resection 0.439 0.496 0.047
***
0.005 1.143
***
0.015
Plastic operation on breast 0.051 0.220 0.115
***
0.011 1.299
***
0.028
Total Mastectomy 0.395 0.489 0.116
***
0.003 2.063
***
0.020
Multiple episode DV 0.008 0.090 0.017 0.033 1.602
***
0.095
Mortality DV 0.000 0.015 0.084 0.051 1.382 0.286
Adverse event DV 0.001 0.029 0.002 0.060 1.279 0.203
Infection DV: UTI 0.002 0.045 0.099
**
0.037 1.339
***
0.108
Infection DV: post-operative infection 0.002 0.047 0.158
***
0.036 1.932
***
0.179
Infection DV: C difficile 0.000 0.012 0.022 0.080 1.917 0.986
Constant 7.616
***
0.009 7.704
***
0.008 1.144
***
0.027 1.941
***
0.046
alpha 0.044
***
0.005 0.117
***
0.005
N 30025 30025 30025 30025
r2_a / adjusted deviance r^2 0.736 0.722 0.535 0.391
# Exponentiated coefficients; DV: dummy variable; w: with; w/o: without; cc: complications and comorbidities; icc: intermediate cc; mcc: major cc; UTI: urinary tract infection.
* p < 0.05, ** p < 0.01, *** p < 0.001
English hospitals can improve their use of resources: an analysis of costs and length of stay for ten treatments 25
Figure 6: Variation in patient cost by HRG: breast cancer
Notes: see Table 6 for HRG definitions. HRG4: is the reference category (most populated HRG) for the breast cancer analysis. HRGs
are ranked in ascending order of PbR tariff.
Box plot shows, from top to bottom: outside values (dots), upper adjacent value, 75
th
percentile (upper hinge), median, 25
th
percentile (lower hinge) and lower adjacent value.
Hospital performance
Our analysis included 139 hospitals that cared for patients suffering breast cancer. The variation in
unexplained average hospital costs ranged from 11% below to 10% above the national mean; for LoS, the
corresponding figures were 72% and 118%. None of the hospital characteristics that we examined was
significant in explaining this variation.
Figure 7: Hospital fixed effects: breast cancer
Average costs and LoS were more closely correlated for breast cancer (r=0.51; P<0.05) than for any of the
other treatments we examined. Most of the hospitals where average costs were highest were also among
those hospitals with the longest average LoS, notably Leeds Teaching Hospitals NHS Trust, Queen Elizabeth
Hospital NHS Trust, Christie Hospital NHS Foundation Trust, Mid Yorkshire Hospitals NHS Trust, and
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Airedale NHS Trust. In the both graphs in Figure 7, one hospital has a wide confidence interval. This
hospital, the Princess Alexandra Hospital NHS Trust, undertook fewer than 10 mastectomies. For these
patients, costs and LoS were highly variable and our models were unable to account for the spread of these
data.
Box 7: Hospitals in top/bottom 5% by rank: breast cancer (mastectomy)
cost
rank
LoS
rank
Hospital Name LoS
rank
cost
rank
Hospital Name
1 111 Blackpool, Fylde & Wyre Hospitals
NHS Trust
1 31 Hereford Hospitals NHS Trust
2 50 South Warwickshire General Hospitals
NHS Trust
2 52 Southampton University
Hospitals NHS Trust
3 84 Frimley Park Hospital NHS Foundation
Trust
3 69 North West London Hospitals
NHS Trust
4 11 Scarborough & North East Yorkshire
Health Care NHS Trust
4 71 Guy's & St Thomas' NHS
Foundation Trust
5 15 Northampton General Hospital NHS
Trust
5 39 Luton & Dunstable Hospital NHS
Foundation Trust
6 12 The Rotherham NHS Foundation Trust 6 49 North Bristol NHS Trust
7 48 East Lancashire Hospitals NHS Trust 7 17 North Tees & Hartlepool NHS
Trust
133 125 Basildon & Thurrock University
Hospitals NHS Foundation Trust
133 86 Barnet & Chase Farm Hospitals
NHS Trust
134 106 Salford Royal NHS Foundation Trust 134 95 Northern Lincolnshire & Goole
Hospitals NHS Trust
135 128 Mid Yorkshire Hospitals NHS Trust 135 136 Christie Hospital NHS Foundation
Trust
136 135 Christie Hospital NHS Foundation
Trust
136 35 Portsmouth Hospitals NHS Trust
137 130 Queen Elizabeth Hospital NHS Trust 137 79 Homerton University Hospital
NHS Foundation Trust
138 131 Leeds Teaching Hospitals NHS Trust 138 126 Royal Free Hampstead NHS Trust
139 95 Essex Rivers Healthcare NHS Trust 139 132 Airedale NHS Trust
English hospitals can improve their use of resources: an analysis of costs and length of stay for ten treatments 27
Childbirth
Literature review
x Laudicella et al., (2010) examined cost variations across obstetrics departments in England.
o They used a two-stage multi-level approach and patient level data for almost one
million patients discharged from obstetrics departments in 2005/06.
o Compared to the reference case (normal delivery w/o cc), costs of other maternity HRGs
were higher.
o They also found that a higher number of procedures and diagnoses significantly
increased costs.
x Comas et al., (2011) used a multivariate regression model to estimate the costs of childbirth in
Spain (Catalonia).
o Using patient level data, they found that the costs and LoS for caesarean sections and
assisted deliveries were significantly higher than for normal delivery.
x Participants in the EuroDRG project used a hierarchical model to analyse the drivers of cost
and LoS for childbirth in ten European countries (Or et al., 2012).
o They found that younger mothers (<21) had significantly longer lengths of stay and
higher costs in most countries, whilst older mothers (>35) had longer stays in Austria
and Ireland
o Being transferred into hospital significantly increased cost and LoS in most countries
while transfers out of hospital significantly reduced LoS and cost
o Having multiple deliveries significantly increased LoS and costs in all counties, as did
having a c-section
o Cases of stillbirth led to shorter stays but did not entail major differences in cost.
Patient-level analysis
Data were available for 549,036 women undergoing childbirth in 144 hospitals, making this the largest
sample of patients for the set of treatments we consider. Results of our analyses of their costs and LoS
are reported in Table 7. Patient characteristics that are significant (P<0.001) explanators of variations in
cost or LoS are summarised in Box 8 below.
Box 8: Patient characteristics that are significant explanators of variations in cost or LOS for childbirth
Variables Our Findings
Dependent
variables
(mean)
Cost  £1,611
LoS  2.4
Demographics Women aged over 35 had 1% higher cost and 4% longer LoS than the 24-27 age group.
Costs and LoS were both significantly higher among women from poorer areas.
Admission/
Discharge
Emergency cases had 3% higher cost and 18% longer LoS.
Patients transferred in had 3% higher cost and 19% longer LoS while those transferred out were 5%
cheaper and had 25% shorter stays. Women cared for by multiple consultants had higher cost and LoS.
Case
Complexity
Patients with a greater total number of diagnoses or procedures had higher costs and LoS. However,
women diagnosed with obesity had 10% shorter stays.
LoS was 12% higher in patients who were diagnosed with at least two non-severe, or with one major,
Charlson comorbidity. However, if a single non-severe Charlson comorbidity was diagnosed, patient
costs were 1% lower and LoS 8% shorter.
HRGs Relative to the base HRG normal delivery without complications in adults (NZ01B), patient cost was
higher for all other specified HRGs by between 3% and 101%. Cost rose in line with the tariff paid for
each HRG.
Patient LoS followed the same general pattern as cost, ranging from 11% to 134% higher than the
reference group.
Treatment
Specific
Patient cost and LoS were higher whenmultiple births or an episiotomy occurred.
In the 0.5% of still birth cases, LoS was 9% shorter.
Quality Spells involving adverse events had higher cost and LoS.
Patients diagnosed with a UTI or C. difficile had longer LoS of 14% and 64% respectively (Figure 8).
However, the C difficile affected less than 0.1% of women.
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Table 7: Cost and LoS in childbirth patients: patient-level analysis
Log of cost LoS #
Explanatory variable mean sd Full Model Partial Model Full Model Partial Model
ɴ se ɴ se ɴ se ɴ se
Age 1: 1 to 23 0.214 0.410 0.004** 0.002 0.004** 0.002 0.998 0.003 0.999 0.003
Age 2: 24 to 27 0.200 0.400 ref ref ref ref ref ref ref ref
Age 3: 28 to 31 0.226 0.418 0.000 0.002 0.000 0.002 1.007* 0.003 1.008* 0.003
Age 4: 32 to 35 0.207 0.405 0.002 0.002 0.001 0.002 1.009** 0.003 1.007* 0.003
Age 5: 36+ 0.153 0.360 0.011*** 0.002 0.009*** 0.002 1.035*** 0.004 1.030*** 0.004
Gender 0.000 0.000 omitted omitted omitted omitted
Socioeconomic status 0.193 0.140 0.033*** 0.004 0.028*** 0.004 1.112*** 0.010 1.097*** 0.01
Emergency admission DV 0.004 0.067 0.028*** 0.008 0.030*** 0.008 1.179*** 0.021 1.184*** 0.021
Transfer-in DV 0.007 0.083 0.031*** 0.006 0.030*** 0.006 1.183*** 0.015 1.181*** 0.015
Transfer-out DV 0.006 0.076 -0.049*** 0.007 -0.048*** 0.007 0.753*** 0.013 0.755*** 0.014
Total number diagnoses 3.215 1.432 0.025*** 0.000 0.026*** 0.000 1.103*** 0.001 1.107*** 0.001
Total number procedures 2.408 1.215 0.039*** 0.000 0.043*** 0.000 1.095*** 0.001 1.108*** 0.001
One non-severe Charlson comorbidity 0.032 0.177 -0.014*** 0.003 -0.017*** 0.003 0.921*** 0.005 0.916*** 0.005
At least 1 severe or 2 non-severe Charlson comorbidities 0.001 0.029 0.041** 0.015 0.038* 0.015 1.128*** 0.037 1.120*** 0.038
Hypertension comorbidity DV 0.000 0.016 0.016 0.033 0.018 0.033 1.144 0.083 1.145 0.083
Obesity comorbidity 0.006 0.078 -0.002 0.007 -0.008 0.007 0.895*** 0.010 0.885*** 0.01
HRG1: NZ01B DV; Normal delivery >18 w/o cc 0.535 0.499 ref ref ref ref ref ref ref ref
HRG2: NZ01D DV; Normal delivery <19 w/o cc 0.025 0.156 0.033*** 0.004 0.033*** 0.004 1.108*** 0.008 1.109*** 0.008
HRG3: NZ02B DV; Assisted delivery w/o cc 0.034 0.181 0.209*** 0.002 0.230*** 0.002 1.209*** 0.006 1.276*** 0.007
HRG4: NZ01A DV; Normal delivery >18 with cc 0.131 0.338 0.341*** 0.002 0.341*** 0.002 1.505*** 0.006 1.505*** 0.006
HRG5: NZ02A DV; Assisted delivery w cc 0.016 0.127 0.419*** 0.004 0.436*** 0.003 1.459*** 0.012 1.531*** 0.012
HRG6: NZ03A DV; Caesarean Section >18 0.086 0.280 0.519*** 0.002 0.514*** 0.001 2.070*** 0.007 2.041*** 0.007
HRG7: NZ03C DV; Caesarean Section w cc 0.150 0.357 0.700*** 0.001 0.696*** 0.001 2.350*** 0.007 2.305*** 0.006
HRG8: Other non-reference HRG DV 0.023 0.149 0.329*** 0.004 0.336*** 0.004 1.745*** 0.012 1.741*** 0.012
Stillbirth 0.005 0.072 -0.010 0.008 -0.017* 0.008 0.907*** 0.016 0.889*** 0.016
Multiple delivery 0.015 0.120 0.041*** 0.003 0.035*** 0.003 1.300*** 0.009 1.287*** 0.009
Episiotomy 0.143 0.350 0.036*** 0.001 1.109*** 0.004
Multiple episode DV 0.043 0.203 0.089*** 0.002 1.091*** 0.006
Mortality DV 0.000 0.004 -0.080 0.135 0.739 0.317
Adverse event DV 0.020 0.141 0.044*** 0.003 1.167*** 0.007
Infection DV: UTI 0.007 0.083 0.004 0.006 1.141*** 0.014
Infection DV: post-operative infection 0.000 0.005 0.112 0.116 1.320 0.198
Infection DV: C difficile 0.000 0.006 0.137 0.096 1.728*** 0.239
Constant 6.856*** 0.002 6.852*** 0.002 0.899*** 0.004 0.891*** 0.004
alpha 0.064*** 0.003 0.065*** 0.003
N 549036 549036 549036 549036
r2_a / adjusted deviance r^2 0.547 0.546 0.341 0.339
Type nbreg nbreg
# Exponentiated coefficients; DV: dummy variable; w: with; w/o: without; cc: complications and comorbidities; icc: intermediate cc; mcc: major cc; UTI: urinary tract infection.
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Figure 8: Variation in LoS by C. difficile: childbirth
Hospital performance
There was a wide variation in the fixed effects capturing average hospital costs, purged of the
influence of patient characteristics. These average costs ranged from 18% below the national
hospital mean to 9% above. Variation in average LoS was more pronounced (range: 32% below to
62% above the national mean). None of the hospital level variables we tested explained between-
hospital variation in cost or LoS.
Figure 9: Hospital fixed effects: childbirth
There was little relation between cost and LoS for those hospitals at the lower end of either
distribution. A couple of hospitals with relatively high average costs also had long average LoS, these
being Shrewsbury & Telford Hospital NHS Trust, and Northumbria Healthcare NHS Foundation Trust.
There was no correlation between average costs and LoS (r=-0.02; P=0.7901).
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Box 9: Hospitals in top/bottom 5% by rank: childbirth
cost
rank
LoS
rank
Hospital Name LoS
rank
cost
rank
Hospital Name
1 133 York Hospitals NHS Foundation
Trust
1 94 Royal West Sussex NHS Trust
2 129 The Royal Wolverhampton
Hospitals NHS Trust
2 18 West Suffolk Hospitals NHS Trust
3 107 Poole Hospital NHS Trust 3 118 Doncaster & Bassetlaw Hospitals
NHS Foundation Trust
4 138 Weston Area Health NHS Trust 4 9 University Hospital Of North
Staffordshire NHS Trust
5 101 Queen Elizabeth Hospital NHS
Trust
5 30 Bedford Hospital NHS Trust
6 52 North Cheshire Hospitals NHS
Trust
6 86 Barnet & Chase Farm Hospitals
NHS Trust
7 13 Worthing & Southlands
Hospitals NHS Trust
7 46 University Hospitals Of Leicester
NHS Trust
138 65 Barking, Havering & Redbridge
Hospitals NHS Trust
138 4 Weston Area Health NHS Trust
139 12 Harrogate & District NHS
Foundation Trust
139 36 Barts & The London NHS Trust
140 127 Northumbria Healthcare NHS
Foundation Trust
140 134 Plymouth Hospitals NHS Trust
141 134 Shrewsbury & Telford Hospital
NHS Trust
141 68 South Warwickshire General
Hospitals NHS Trust
142 85 Tameside & Glossop Acute
Services NHS Trust
142 49 Stockport NHS Foundation Trust
143 51 Gateshead Health NHS
Foundation Trust
143 121 Central Manchester &
Manchester Children's University
Hospitals NHS Trust
144 113 University Hospitals Of
Morecambe Bay NHS Trust
144 56 King's College Hospital NHS
Foundation Trust
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Cholecystectomy
Literature review
x Carbonell et al., (2005) used data from the U.S. Healthcare Cost and Utilisation Project
Nationwide Inpatient Sample database for the year 2000 to examine the influence of
patient and hospital characteristics on cholecystectomy costs (with charges as a proxy) and
LoS.
o They found that both LoS and costs were significantly lower for laparoscopic
cholecystectomy.
o Increasing age was associated with longer LoS and higher costs.
x A study by Kuy et al., (2011) used U.S. inpatient data over a 7 year period (1999-2006) and
found that older patients had longer LoS and higher costs than younger patients.
x As part of the EuroDRG project, researchers used a hierarchical model to identify the
drivers of cost and LoS for cholecystectomy at individual and hospital level across ten
European countries (Paat-Ahi et al., 2012).
o They found that increasing age had a significantly positive effect on cost and LoS in
all countries.
o Patients with more diagnoses and procedures had higher costs and LoS in most
countries.
o Emergency cases typically had significantly higher costs and longer LoS, while
patients who died in hospital had significantly shorter stays in all countries.
o Laparoscopic procedures significantly reduced cost and LoS compared to open
procedures.
Patient-level analysis
Results from our analyses of the costs and LoS for the 43,917 patients who had cholecystectomy in
148 hospitals during 2007/8 are reported in Table 8. Significant (P<0.001) variables are highlighted
below.
Box 10: Patient characteristics that are significant explanators of variations in cost or LOS for
cholecystectomy
Variables Our Findings
Dependent variables
(mean)
Cost  £1,971
LoS  2.3
Demographics Patients aged over 57 had 3% higher costs than those aged 37-47.
Patient LoS also increased with age.
Patients living in poorer areas had higher costs and stayed longer than those from better off areas.
Male patients had longer LoS but this effect was no longer significant at the 0.1% level when quality measures
were included in the model.
Admission/
Discharge
The 10% of cases treated as emergencies cost 66% more and stayed 2.3 times longer than elective cases. These
differences translate to an increase of approximately £1,000 and 5 days respectively per case.
Patients transferred out stayed 36% longer than patients treated in a single hospital.
Patients cared for by more than one consultant stayed in hospital 33% longer than those under the care of a
single consultant.
Case
Complexity
Patients diagnosed with a larger number of conditions had higher cost and LoS.
A higher number of procedures performed also increased patient cost and LoS.
The more specific comorbidities considered did not significantly impact on either dependant variable.
17% of patients were diagnosed with hypertension. These appear to have 9% lower LoS, but this impact is only
significant at the 0.1% level when quality was not taken into account. .
HRGs Relative to the base HRG Cholecystectomy without complications (GA10B), patients had higher costs and longer
LoS if complications occurred (GA10A, and GA07A) or were assigned to a more complex category 3 HRG (GA07B
and GA07A).
The broader HRG covering general abdominal procedures with major complications (FZ12A) had a similar impact
on patient cost to GA07B but no significant impact on LoS.
Treatment
Specific
When successful, a laparoscopic cholecystectomy reduced patient cost by 7% and LoS by 49%.
However, if the laparoscopic approach failed, patients had 5% higher costs and 17% longer LoS than patients that
had the open procedure.
Quality For the 0.3% of patients that suffered a post operative infection LoS was 85% longer.
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Table 8: Cost and LoS in cholecystectomy patients: patient-level analysis
Log of cost LoS #
Explanatory variable mean sd Full Model Partial Model Full Model Partial Model
ɴ se ɴ se ɴ se ɴ se
Age 1: 1 to 36 0.209 0.407 -0.006 0.004 -0.007 0.004 0.950*** 0.013 0.932*** 0.013
Age 2: 37 to 47 0.212 0.409 ref ref ref ref ref ref ref ref
Age 3: 48 to 57 0.193 0.395 0.013** 0.004 0.014** 0.004 1.064*** 0.015 1.075*** 0.016
Age 4: 58 to 67 0.205 0.404 0.029*** 0.004 0.031*** 0.004 1.151*** 0.021 1.183*** 0.022
Age 5: 68+ 0.181 0.385 0.063*** 0.005 0.067*** 0.005 1.400*** 0.021 1.462*** 0.023
Gender 0.235 0.424 0.004 0.003 0.008* 0.003 1.033** 0.011 1.094*** 0.013
Socioeconomic status 0.164 0.122 0.045*** 0.012 0.046*** 0.012 1.241*** 0.048 1.245*** 0.053
Emergency admission DV 0.097 0.296 0.506*** 0.007 0.513*** 0.007 3.333*** 0.048 3.789*** 0.049
Transfer-in DV 0.006 0.075 -0.05 0.027 -0.048 0.027 1.163* 0.083 1.193* 0.098
Transfer-out DV 0.003 0.058 0.061 0.032 0.076* 0.032 1.355*** 0.121 1.554*** 0.143
Total number diagnoses 2.268 1.665 0.006*** 0.002 0.010*** 0.001 1.077*** 0.005 1.117*** 0.005
Total number procedures 2.318 0.889 0.035*** 0.003 0.033*** 0.002 1.203*** 0.008 1.188*** 0.007
One non-severe Charlson comorbidity 0.135 0.342 0.014** 0.005 0.011* 0.005 0.99 0.014 0.965* 0.015
At least 1 severe or 2 non-severe Charlson comorbidities 0.024 0.154 0.012 0.011 0.007 0.011 1.02 0.031 0.978 0.033
Hypertension comorbidity DV 0.166 0.372 0.006 0.004 0.002 0.004 0.945** 0.02 0.908*** 0.019
Obesity comorbidity DV 0.022 0.147 0.01 0.009 0.011 0.009 1.041 0.029 1.042 0.03
HRG1: GA10B DV; Cholecystectomy w/o cc 0.757 0.429 ref ref ref ref ref ref ref ref
HRG2: GA10A DV; Cholecystectomy wcc 0.162 0.369 0.188*** 0.005 0.191*** 0.005 1.269*** 0.018 1.303*** 0.02
HRG3: GA08B DV; Hepatobiliary Proc cat2 w/o cc 0.012 0.111 -0.011 0.03 0.002 0.031 0.983 0.056 1.114 0.067
HRG4: GA07B DV; Hepatobiliary Proc cat3 w/o cc 0.013 0.115 0.333*** 0.018 0.357*** 0.018 1.686*** 0.064 2.194*** 0.087
HRG5: FZ12A DV; General Abdominal: v. major/major proc wmcc 0.018 0.133 0.301*** 0.018 0.310*** 0.018 1.089* 0.044 1.194*** 0.05
HRG6: GA07A DV; Hepatobiliary Proc cat3 wcc 0.01 0.099 0.536*** 0.022 0.576*** 0.022 1.580*** 0.067 2.225*** 0.094
HRG7: Other non-reference HRG DV 0.027 0.162 0.270*** 0.018 0.299*** 0.018 1.538*** 0.048 2.051*** 0.065
Laparoscopy DV 0.898 0.303 -0.071*** 0.008 0.512*** 0.011
Failed laparoscopy DV 0.044 0.205 0.052*** 0.011 1.174*** 0.029
Multiple episode DV 0.049 0.215 0.003 0.009 1.331*** 0.028
Mortality DV 1E-03 0.031 -0.073 0.08 0.625** 0.109
Adverse event DV 0.009 0.093 0.032 0.022 1.071 0.062
Infection DV: UTI 0.002 0.046 0.061 0.038 1.317** 0.129
Infection DV: post-operative infection 0.003 0.055 0.044 0.034 1.848*** 0.134
Infection DV: C difficile 5E-04 0.021 -0.007 0.093 1.482 0.303
Constant 7.313*** 0.009 7.245*** 0.006 1.149*** 0.03 0.596*** 0.012
alpha 0.194*** 0.014 0.248*** 0.015
N 43917 43917 43917 43917
r2_a / adjusted deviance r^2 0.629 0.626 0.598 0.544
# Exponentiated coefficients; DV: dummy variable; w: with; w/o: without; cc: complications and comorbidities; icc: intermediate cc; mcc: major cc; UTI: urinary tract infection.
* p < 0.05, ** p < 0.01, *** p < 0.001
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Hospital performance
Figure 10: Hospital fixed effects: cholecystectomy
Patients treated at Gloucestershire Hospitals NHS Foundation Trust had both the lowest costs and
shortest LoS nationally, after adjusting for casemix differences. Hospital costs ranged from 17% below to
13% above the national mean hospital cost; the corresponding figures for LoS were 82% and 90%
respectively. Overall there was a positive rank correlation between average cost and LoS (r=0.39;
P<0.05), and most of the hospitals at the extreme upper end of the cost distribution were also at the
upper end of the LoS distribution. In Weston Area Health NHS Trust, one patient had a stay of 285 days.
This underlies the wide confidence interval (i.e. high level of uncertainty) around the estimate of the
mean LoS for this hospital (Figure 10).
Box 11: Hospitals in top/bottom 5% by rank: cholecystectomy
cost
rank
LoS
rank
Hospital Name LoS
rank
cost
rank
Hospital Name
1 1 Gloucestershire Hospitals NHS
Foundation Trust
1 1 Gloucestershire Hospitals NHS
Foundation Trust
2 76 Kingston Hospital NHS Trust 2 23 The Royal Wolverhampton Hospitals
NHS Trust
3 94 South Warwickshire General
Hospitals NHS Trust
3 73 Winchester & Eastleigh Healthcare NHS
Trust
4 45 Southampton University Hospitals
NHS Trust
4 9 Royal Berkshire Hospital NHS
Foundation Trust
5 67 Salford Royal NHS Foundation Trust 5 31 Hinchingbrooke Health Care NHS Trust
6 19 United Bristol Healthcare NHS Trust 6 34 Buckinghamshire Hospitals NHS Trust
7 65 York Hospitals NHS Foundation Trust 7 68 South Devon Healthcare NHS
Foundation Trust
142 98 Scarborough & North East Yorkshire
Health Care NHS Trust
142 122 Wrightington, Wigan & Leigh NHS Trust
143 127 Lancashire Teaching Hospitals NHS
Foundation Trust
143 124 North Middlesex University Hospital
NHS Trust
144 132 Barking, Havering & Redbridge
Hospitals NHS Trust
144 145 Dudley Group Of Hospitals NHS Trust
145 144 Dudley Group Of Hospitals NHS Trust 145 116 Sheffield Teaching Hospitals NHS
Foundation Trust
146 130 Leeds Teaching Hospitals NHS Trust 146 120 Gateshead Health NHS Foundation
Trust
147 133 University Hospitals Coventry &
Warwickshire NHS
147 63 Weston Area Health NHS Trust
148 138 Birmingham Children's Hospital NHS
Foundation Trust
148 133 Chelsea & Westminster Hospital NHS
Foundation Trust
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Coronary Artery Bypass Graft (CABG)
Literature review
x Bestawros et al., (2005) analysed cost data obtained for over 12,000 patients from 9 hospitals
(4 in Canada and 5 in the U.S.). Log linear regression modelling was used to examine the
impact of hospital LoS and costs for CABG.
o Patients older than 75 years of age experienced 20% longer lengths of stay.
o Comorbidities such as neoplasm, COPD and diabetes were all associated with increased
stay ranging from 5% for diabetes patients to 17% for neoplasm.
o Having had a previous myocardial infarction, hypertension or a lipid metabolism
disorder reduced length of stay by 3% 6% and 7% respectively.
o Being hospitalised in the US had the most significant impact on overall costs  US
patients were 84% more costly than their Canadian equivalent.
o Patients aged 75 and over had 11% higher cost.
o Having preoperative congestive heart failure (CHF) increased costs by 45%
o After adjusting for age and comorbidities, women had a 10% longer stay and a 7%
increase in overall cost compared to men.
x Butterworth et al., (2000) analysed data from surveys in 1995 and 1997 to investigate the
effect of gender on different aspects of LoS.
o Mixed-effects linear models were used to test for associations between gender and LoS.
o Covariates included age, weight, DRG, congestive heart failure, history of myocardial
infarction, diabetes, and chronic obstructive lung disease.
o After adjusting for preoperative covariates, women were found to have longer ICU
(Intensive care unit) LoS and total postoperative LoS than males.
x Rosen et al., (1999) analysed detailed clinical data on Medicare patients to identify predictors
of post operative LoS.
o Significant predictors included increasing age, being female, history of chronic
obstructive pulmonary disease, cerebrovascular disease and preoperative placement of
an intra-aortic balloon pump.
o They found significant hospital level variations even when adjusting for preoperative
patient characteristics and postoperative complications.
x Saleh et al., (2009) analysed cost data on New York State residents who underwent a CABG in
2003.
o Older patients and women had higher costs.
o Higher costs were also associated with a lower ejection fraction, the duration of CAGB
admission, the occurrence of myocardial infarction, carotid/cerebrovascular disease,
congestive heart failure and renal failure.
x Naglie et al., (1999) found that CABG was more costly in older patients after adjusting for
disease severity and co morbidities such as the presence of complications, diabetes
hypertension and renal failure.
x Toor et al., (2009) examined whether complication rates and resource utilization among
elderly patients undergoing CABG differed from their younger counterparts.
o They collected demographic and clinical data from patients undergoing first-time
isolated CABG.
o Multivariate logistic regression analysis showed that age greater than or equal to 75
years was a significant predictor of postoperative LoS.
x Woods et al., (2003) assessed differences between men and women undergoing CABG surgery
using an 8 year cohort study.
o Using multiple regression analysis the authors looked at the impact of gender on 15
comorbidities and 13 health outcomes.
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o Women had more comorbidities at surgical presentation compared with men. In
particular, women had significantly higher levels of diabetes, hypercholesterolemia,
hypertension, previous cerebrovascular disease and reduced functional capacity.
o Women had significantly higher rates of morality, intraoperative, renal and pulmonary
complications as well as longer lengths of stay in hospital and in the intensive care unit.
o After controlling for age and comorbidities, women still had significantly longer LoS.
x Kurki et al., (2003) used data from the New York State Statewide Planning and Research
Cooperative System (SPARCS) database to investigate the association between preoperative
risk factors and postoperative LoS in CABG patients.
o Patients were subdivided into an emergency group and an elective group.
o Using log regression analysis they found that the emergency group had a significantly
longer LoS than elective patients.
x As part of the EuroDRG project researchers used a two-stage model using individual data to
look at the predictors of cost and LoS for the treatment of CABG across hospitals and across
ten countries (Gaughan et al., 2012).
o Patients with a higher number of diagnoses and procedures had significantly higher
costs and longer LoS in almost all countries,
o Acute myocardial infarction (AMI) was the most frequently significant patient level
indicator of cost and LoS. AMI was associated with lower LoS in Austria and lower costs
in England but higher costs in Sweden,
o Postoperative wound infection significantly increased LoS and costs.
Patient-level analysis
During 2007/8 18,875 patients received a CABG in 28 hospitals. Treatment is relatively expensive: on
average, the cost of treating these patients amounted to £7,658 and LoS was 12.5 days. Results of our
analyses of the patient characteristics that might influence cost or LoS are reported in Table 9. In Box 12
below, we highlight significant explanatory variables (P<0.001).
Box12: Patient characteristics that are significant explanators of variations in cost or LOS for CABG
Variables Our Findings
Dependent
variables (mean)
Cost  £7,658
LoS  12.5
Demographics An increase in patient age was associated with significantly longer LoS.
Patients living in poorer areas and female patients also had longer LoS.
Admission/
Discharge
Patients transferred between hospitals had higher cost and longer LoS.
Emergency cases were also associated with significantly longer LoS. When patients were cared for by more
than one consultant, costs were 3% lower but LoS increased by 43%.
Case
Complexity
Patients with more diagnoses or procedures had higher costs and longer LoS.
Patients diagnosed with more than one Charlson comorbidity stayed 10% longer than those with none.
Patients diagnosed with hypertension had 7% shorter LoS but the size of the impact was sensitive to the
inclusion of quality variables.
HRGs Relative to the base HRG 1
st
time CABG (EA14Z), patients who underwent additional revascularisation
procedures or catheterisation (EA20Z) had around 5% higher cost but 10% shorter stays.
Cost was also significantly higher (by 8%) among patients categorised into the HRG Intermediate
Congenital Surgery (EA25Z).
Treatment
Specific
Patient LoS was higher where atrial fibrillation or renal failure was diagnosed.
LoS was also longer when multiple vessels were bypassed or an additional valve procedure performed, but
shorter in patients who had multiple CABGs or if a PTCA was performed. Of these variables, the absolute
impact on LoS ranged from 5% (multiple vessel bypass) to 17% (renal failure).
The occurrence of an AMI was associated with a 4% reduction in cost. However, this variable was only
significant at the 0.1% level when quality measures were not included in the analysis.
Quality Patients who died in hospital stayed 27% shorter than those discharged alive.
Adverse events increased LoS, with the effect ranging from 17% (UTI) to 62% (post operative infection).
Patients had higher costs if they suffered an adverse event or wound infection (Figure 11).
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Table 9: Cost and LoS in CABG patients: patient-level analysis
Log of cost LoS #
Explanatory variable mean sd Full Model Partial Model Full Model Partial Model
ɴ se ɴ se ɴ se ɴ se
Age1: 1-59 0.217 0.412 -0.001 0.006 -0.002 0.006 0.949*** 0.010 0.948*** 0.011
Age2: 60-66 0.186 0.389 ref ref ref ref ref ref ref ref
Age3: 67-71 0.229 0.420 0.001 0.006 0.002 0.006 1.053*** 0.012 1.060*** 0.012
Age 4: 72-76 0.195 0.396 -0.002 0.006 0.000 0.006 1.107*** 0.013 1.118*** 0.014
Age 5: 77+ 0.173 0.378 0.002 0.006 0.003 0.006 1.188*** 0.016 1.211*** 0.016
Gender 0.787 0.410 0.008 0.005 0.008 0.005 0.953*** 0.010 0.950*** 0.010
Socioeconomic status 0.153 0.118 0.030 0.017 0.030 0.017 1.216*** 0.042 1.238*** 0.046
Emergency admission DV 0.107 0.309 -0.005 0.010 -0.017 0.010 1.318*** 0.021 1.533*** 0.024
Transfer-in DV 0.253 0.435 0.0381*** 0.005 0.0324*** 0.005 1.125*** 0.011 1.207*** 0.012
Transfer-out DV 0.072 0.259 0.0317*** 0.009 0.0404*** 0.009 1.226*** 0.023 1.263*** 0.025
Total number diagnoses 6.570 3.298 0.0068*** 0.001 0.0087*** 0.001 1.033*** 0.002 1.050*** 0.002
Total number procedures 3.694 2.309 0.0212*** 0.002 0.0197*** 0.002 1.080*** 0.003 1.103*** 0.003
One non-severe Charlson comorbidity 0.295 0.456 0.003 0.004 0.001 0.004 1.027** 0.009 1.007 0.009
At least 1 severe or 2 non-severe Charlson comorbidities 0.167 0.373 0.0142* 0.006 0.009 0.006 1.101*** 0.014 1.067*** 0.015
Hypertension comorbidity DV 0.604 0.489 -0.0109* 0.004 -0.0150*** 0.004 0.933*** 0.008 0.916*** 0.008
Obesity comorbidity DV 0.043 0.202 -0.014 0.010 -0.018 0.010 1.037* 0.018 1.039* 0.020
HRG1: EA14Z DV; CABG 1
st
0.852 0.355 ref ref ref ref ref ref ref ref
HRG2: EA25Z DV; Intermediate Congenital Surgery 0.017 0.131 0.0794*** 0.022 0.0909*** 0.021 0.916** 0.030 0.927* 0.031
HRG3: EA20Z DV; Other Complex Cardiac Surgery and Re-do's 0.012 0.109 -0.041 0.034 -0.039 0.033 1.107 0.060 1.081 0.054
HRG4: EA16Z DV; CABG 1st + PCI Pacing EP or RFA +/- Catheterisation 0.064 0.244 0.0487*** 0.009 0.0542*** 0.009 0.894*** 0.016 0.872*** 0.017
HRG5: Other non-reference HRG DV 0.055 0.227 -0.2933*** 0.028 -0.2964*** 0.028 1.112*** 0.027 1.182*** 0.031
Unstable Angina 0.072 0.259 -0.0210* 0.010 -0.0266** 0.010 0.977 0.015 1.002 0.016
Atrial Fibrillation 0.228 0.419 0.001 0.005 0.001 0.005 1.058*** 0.011 1.041*** 0.011
Acute myocardial infarction 0.078 0.268 -0.0326** 0.010 -0.0396*** 0.010 1.015 0.017 1.033 0.017
Acute Renal Failure 0.014 0.117 0.037 0.024 0.039 0.024 1.173*** 0.047 1.146** 0.050
Further CABG 0.802 0.399 -0.0139* 0.007 0.943*** 0.011
PTCA DV 0.008 0.091 -0.054 0.033 0.858** 0.042
More than 1 vessel treated simultaneously 0.661 0.473 0.0096* 0.004 1.049*** 0.009
Valve Surgery on Heart 0.159 0.366 0.012 0.007 1.099*** 0.016
Multiple episode DV 0.226 0.418 -0.0290*** 0.007 1.426*** 0.019
Mortality DV 0.025 0.158 -0.0449* 0.019 0.731*** 0.036
Adverse event DV 0.020 0.141 0.0619*** 0.018 1.234*** 0.039
Infection DV: UTI 0.013 0.113 0.009 0.022 1.167*** 0.039
Infection DV: post-operative infection 0.028 0.166 0.0974*** 0.013 1.623*** 0.040
Infection DV: C difficile 0.004 0.064 0.0820* 0.034 1.497*** 0.082
Constant 8.7620*** 0.012 8.7549*** 0.009 5.580*** 0.104 5.068*** 0.087
alpha 0.111*** 0.003 0.135*** 0.003
N 18875 18875 18875 18875
r2_a / adjusted deviance r^2 0.52 0.517 0.626 0.57
# Exponentiated coefficients; DV: dummy variable; EP: electrophysiology; PCI: Percutaneous coronary intervention; PTCA: Percutaneous transluminal coronary angioplasty; RFA: radiofrequency ablation; UTI: urinary
tract infection. * p < 0.05, ** p < 0.01, *** p < 0.001
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Figure 11: Variation in LoS by wound infection: CABG
Hospital performance
Only 28 hospitals provided CABG treatment. After adjusting for patient casemix, there was no
correlation between average costs and LoS among these hospitals (r= -0.15, P=0.4407). LoS was
particularly high in University Hospital Birmingham NHS Foundation Trust, as indicated by its position at
the extreme of the LoS distribution, but it reported relatively low costs. In contrast, average LoS was
lowest at the Cardiothoracic Centre - Liverpool NHS Trust but its costs were among the highest
nationally for this treatment. Costs ranged from 10% below to 7% above the national mean, but LoS
was more variable (32% below to 66% above).
Figure 12: Hospital fixed effects: CABG
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Box 13: Hospitals in top/bottom 10% by rank: CABG
cost
rank
LoS
rank
Hospital Name LoS
rank
cost
rank
Hospital Name
1 11 University Hospitals Of Leicester NHS
Trust
1 25 The Cardiothoracic Centre -
Liverpool NHS Trust
2 28 University Hospital Birmingham NHS
Foundation Trust
2 11 Royal Brompton & Harefield NHS
Trust
3 13 The Newcastle Upon Tyne Hospitals
NHS Foundation Trust
3 19 Plymouth Hospitals NHS Trust
4 12 St George's Healthcare NHS Trust 4 18 King's College Hospital NHS
Foundation Trust
25 1 The Cardiothoracic Centre - Liverpool
NHS Trust
25 22 Guy's & St Thomas' NHS
Foundation Trust
26 26 Blackpool, Fylde & Wyre Hospitals
NHS Trust
26 26 Blackpool, Fylde & Wyre Hospitals
NHS Trust
27 16 Basildon & Thurrock University
Hospitals NHS Foundation Trust
27 10 Barts & The London NHS Trust
28 23 Leeds Teaching Hospitals NHS Trust 28 2 University Hospital Birmingham
NHS Foundation Trust
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Inguinal hernia repair
Literature review
x Much of the research in the area of inguinal hernia has concentrated on the comparison
between open and laparoscopic procedures
o Kuhry et al., (2007) conducted a systematic review of randomised trials comparing
total extraperitoneal (TEP) with open mesh or sutured repair. The review included
4,231 patients from 23 trials. In 10 of 15 trials that assessed time in theatre, TEP
repair was associated with significantly (P<0.05) longer surgery time than open
repair. A shorter postoperative hospital stay after TEP repair than after open repair
was reported in 6 of 11 trials. Hospital costs were significantly higher for TEP than for
open repair.
o McCormack et al., (2005) conducted a systematic review of the effectiveness and
cost-effectiveness of laparoscopic procedures for treating inguinal hernia. Thirty-
seven RCTs and quasi-RCTs met the inclusion criteria on effectiveness and 14
economic evaluations were reviewed. Relative to open repair, laparoscopic repair
was found to cost about £300-350 more per patient.
x Researchers on the EuroDRG project used individual patient level data to analyse the cost
and LoS drivers for the treatment of inguinal hernia in ten countries (O' Reilly et al., 2012).
o They found that costs and LoS increased with age.
o A higher number of diagnoses and procedures led to higher costs and longer lengths
of stay.
o Compared to elective patients, emergency cases had statistically higher costs and
LoS in almost all countries.
o Having a principal diagnosis of bilateral inguinal hernia (without obstruction or
gangrene) resulted in significantly higher costs and longer lengths of stay when
compared to the reference case - an uncomplicated principal diagnosis of
unilateral/unspecified inguinal hernia.
o Costs were higher still for those hernia patients with obstruction or gangrene.
o Having a laparoscopic procedure rather than open surgery significantly reduced LoS
in Ireland and Austria but increased costs in five of the seven countries that analysed
cost data.
Patient-level analysis
Results from our analyses of the costs and LoS for the 64,155 patients who had an inguinal hernia
repair in 151 hospitals during 2007/8 are reported in Table 10. The mean cost of hernia repair
amounts to £1,221 and average LoS is less than one day, the majority of such patients being treated
on a day case basis. Significant (P<0.001) variables that explain cost and LoS are highlighted in Box
14.
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Table 10: Cost and LoS in inguinal hernia patients: patient-level analysis
Log of cost LoS #
Explanatory variable mean sd Full Model Partial Model Full Model Partial Model
ɴ se ɴ se ɴ se ɴ se
Age 1: 1 to 42 0.203 0.402 -0.016*** 0.004 -0.017*** 0.004 0.820*** 0.021 0.820*** 0.021
Age 2: 43 to 56 0.197 0.398 ref ref ref ref ref ref ref ref
Age 3: 57 to 65 0.206 0.404 0.017*** 0.004 0.017*** 0.004 1.206*** 0.027 1.211*** 0.027
Age 4: 66 to 74 0.196 0.397 0.060*** 0.004 0.060*** 0.004 1.693*** 0.037 1.701*** 0.037
Age 5: 75+ 0.199 0.399 0.114*** 0.004 0.114*** 0.004 2.389*** 0.05 2.422*** 0.051
Gender 0.925 0.264 -0.021*** 0.005 -0.021*** 0.005 0.888*** 0.02 0.888*** 0.02
Socioeconomic status 0.147 0.113 0.063*** 0.012 0.061*** 0.012 1.748*** 0.105 1.738*** 0.105
Emergency admission DV 0.042 0.201 0.477*** 0.01 0.484*** 0.010 4.125*** 0.108 4.502*** 0.116
Transfer-in DV 0.003 0.056 -0.05 0.032 -0.045 0.032 1.300*** 0.1 1.325*** 0.100
Transfer-out DV 0.003 0.051 0.061* 0.031 0.069* 0.031 1.599*** 0.164 1.738*** 0.165
Total number diagnoses 1.921 1.430 0.036*** 0.002 0.036*** 0.002 1.247*** 0.008 1.265*** 0.008
Total number procedures 2.315 0.669 0.003 0.003 0.011*** 0.002 1.105*** 0.014 1.104*** 0.013
One non-severe Charlson comorbidity 0.105 0.307 -0.004 0.006 -0.003 0.006 0.937** 0.022 0.926** 0.022
At least 1 severe or 2 non-severe Charlson comorbidities 0.027 0.163 0.012 0.01 0.012 0.010 0.918* 0.032 0.907** 0.032
Hypertension comorbidity 0.163 0.370 -0.017*** 0.004 -0.016*** 0.004 0.898*** 0.017 0.881*** 0.017
Obesity comorbidity 0.002 0.048 0.034 0.035 0.034 0.035 1.03 0.099 1.012 0.096
HRG1: FZ18C DV; Inguinal Umbilical or Femoral Hernia Repairs >18
w/o cc
0.852 0.355 ref ref ref ref ref ref ref ref
HRG2: FZ18D DV; Inguinal Umbilical or Femoral Hernia Repairs <19 0.023 0.148 -0.195*** 0.012 -0.185*** 0.012 0.472*** 0.038 0.501*** 0.039
HRG3: FZ18B DV; Inguinal Umbilical or Femoral Hernia Repairs >18 w
icc
0.052 0.221 0.028*** 0.008 0.027*** 0.008 1.415*** 0.042 1.411*** 0.043
HRG4: FZ18A DV; Inguinal Umbilical or Femoral Hernia Repairs >18 w
mcc
0.061 0.240 0.082*** 0.007 0.082*** 0.007 1.187*** 0.031 1.188*** 0.032
HRG5: Other non-reference HRG DV 0.013 0.113 0.202*** 0.02 0.203*** 0.02 1.571*** 0.078 1.731*** 0.083
Bilateral inguinal hernia, without obstruction or gangrene 0.083 0.276 0.083*** 0.004 0.087*** 0.004 1.668*** 0.033 1.636*** 0.032
Other inguinal hernia diagnoses 0.028 0.164 0.042*** 0.011 0.044*** 0.011 1.038 0.034 1.056 0.034
Connective tissue disorders 0.029 0.167 -0.016* 0.008 -0.016 0.008 0.852*** 0.029 0.845*** 0.030
Laparoscopy DV 0.162 0.369 0.021*** 0.005 0.907*** 0.021
Failed laparoscopy DV 0.004 0.063 0.076*** 0.017 1.486*** 0.106
With implants 0.846 0.361 -0.027*** 0.004 0.849*** 0.015
Multiple episode DV 0.012 0.110 0.059*** 0.016 1.717*** 0.085
Mortality DV 0.001 0.030 -0.117 0.086 0.541** 0.106
Adverse event DV 0.001 0.035 -0.038 0.055 0.953 0.182
Infection DV: UTI 0.001 0.031 0.064 0.056 1.132 0.149
Infection DV: post-operative infection 0.000 0.022 -0.002 0.093 2.625*** 0.658
Infection DV: C difficile 0.000 0.012 0.317 0.18 3.386** 1.29
Constant 6.894*** 0.009 6.857*** 0.008 0.202*** 0.009 0.171*** 0.007
alpha 0.369*** 0.013 0.385*** 0.014
N 64155 64155 64155 64155
r2_a / adjusted deviance r^2 0.575 0.574 0.417 0.410
# Exponentiated coefficients; DV: dummy variable; w: with; w/o: without; cc: complications and comorbidities; icc: intermediate cc; mcc: major cc; UTI: urinary tract infection.
* p < 0.05, ** p < 0.01, *** p < 0.001
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Box 14: Patient characteristics that are significant explanators of variations in cost or LOS for Inguinal hernia
repair
Variables Our Findings
Dependent
variables (mean)
Cost  £1,221
LoS  0.7
Demographics When assessed at the 0.1% level of significance, older patients had higher costs and longer LoS
than younger patients
Male patients had 2% lower costs and 11% shorter LoS than females.
Patients from poorer areas had higher costs and longer LoS.
Admission/
Discharge
Among the 4% of patients treated as emergencies, costs were 61% higher and LoS 4 times
longer, the latter amounting to 3 additional days (compared to an average stay of less than 1
day).
Transferred patients stayed longer than patients treated in a single hospital.
Patients had 6% higher costs and 72% longer LoS when they were cared for by more than one
consultant during their stay.
Case
Complexity
A higher number of diagnoses was associated with higher patient cost and longer LoS. LoS was
also higher when more procedures were performed.
Patients diagnosed with hypertension had 2% lower costs and 10% shorter LoS.
HRGs Relative to the reference HRG (Inguinal Umbilical or Femoral Hernia Repairs >18 without
complications; FZ18C), the 2% of patients aged under 19 had 18% lower costs and 53% shorter
LoS.
Of patients aged over 18, those with intermediate complications (FZ18B) stayed 41% longer
than those without complications and cost 3% more. Patients with major complications (FZ18A)
cost 9% more and stayed 19% longer than the reference group.
Treatment
Specific
Patient cost increased in patients diagnosed with bilateral hernia or with inguinal hernia with
obstruction or gangrene, and also when a laparoscopic procedure was used. LoS was higher if a
laparoscopic approach was used, but failed. However, where laparoscopic procedures were
successful, patient LoS was 9% shorter.The use of implants was associated with lower patient
cost (3%) and shorter LoS (15%).
Patients diagnosed with connective tissue disorders had 15% shorter LoS.
Quality LoS was 163% longer on average among the small proportion (<0.1%) of patients diagnosed
with a post operative infection. The distribution of LoS for patients with and without wound
infection is shown in Figure 13.
Figure 13: Variation in LoS by wound infection: inguinal hernia
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Hospital performance
One hundred and fifty-one hospitals in our study undertook inguinal hernia repair. After adjusting
for casemix differences, average hospital costs varied from 13% below the national mean to 9%
above. In contrast, hospitals mean LoS ranged widely, from 86% below to 136% above the national
hospital mean. In other words, the difference in average LoS across these hospitals was more than
two-fold, though this is not surprising given that mean LoS was only 0.7 days.
Unsurprisingly, given that 60% of patients are treated as day cases, the rank correlation between
average costs and LoS was low (r=0.25; P=0.0021). Hospitals with the lowest average costs nationally
did not have the shortest average LoS, and nor did a shorter average LoS correspond to lower
average cost. At the other extreme, however, some hospitals had both high average costs and longer
average LoS, notably Leeds Teaching Hospitals NHS Trust and Queen Elizabeth Hospital NHS Trust.
One hospital on the left hand side of the LoS graph has very wide confidence intervals. This hospital,
Sheffield Childrens NHS Foundation Trust, treated only 10 patients of whom nine were day cases.
The remaining patient had a LoS of one day.
In general, hospitals undertaking a higher total proportion of hernia cases had a significantly shorter
average LoS, but no other hospital characteristics had a significant influence on either average costs
or LoS.
Figure 14: Hospital fixed effects: inguinal hernia
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Box:15 Hospitals in top/bottom 5% by rank: inguinal hernia
cost
rank
LoS
rank
Hospital Name LoS
rank
cost
rank
Hospital Name
1 133 Salford Royal NHS Foundation
Trust
1 47 The Royal Wolverhampton
Hospitals NHS Trust
2 25 Worthing & Southlands Hospitals
NHS Trust
2 50 Queen Victoria Hospital NHS
Foundation Trust
3 90 Kingston Hospital NHS Trust 3 68 Royal Devon & Exeter NHS
Foundation Trust
4 70 Poole Hospital NHS Trust 4 126 Weston Area Health NHS Trust
5 111 Southampton University
Hospitals NHS Trust
5 75 Hereford Hospitals NHS Trust
6 28 Gloucestershire Hospitals NHS
Foundation Trust
6 52 Hinchingbrooke Health Care NHS
Trust
7 34 Royal Berkshire Hospital NHS
Foundation Trust
7 103 South Devon Healthcare NHS
Foundation Trust
8 53 Sherwood Forest Hospitals NHS
Foundation Trust
8 127 Sheffield Childrens NHS
Foundation Trust
144 125 Barking, Havering & Redbridge
Hospitals NHS Trust
144 122 Sheffield Teaching Hospitals NHS
Foundation Trust
145 24 Nottingham University Hospitals
NHS Trust
145 94 Pennine Acute Hospitals NHS Trust
146 74 George Eliot Hospital NHS Trust 146 88 United Bristol Healthcare NHS
Trust
147 151 Queen Elizabeth Hospital NHS
Trust
147 70 Central Manchester & Manchester
Children's University Hospitals NHS
Trust
148 121 Mid Yorkshire Hospitals NHS
Trust
148 149 Leeds Teaching Hospitals NHS Trust
149 148 Leeds Teaching Hospitals NHS
Trust
149 53 University Hospital Of South
Manchester NHS Foundation Trust
150 18 West Suffolk Hospitals NHS Trust 150 91 Stockport NHS Foundation Trust
151 96 The Hillingdon Hospital NHS Trust 151 147 Queen Elizabeth Hospital NHS Trust
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Hip replacement
Literature review
A number of studies have examined the impact of costs and LoS for hip replacement.
x Foote et al., (2009) analysed 675 consecutive patients who underwent primary total hip
replacement in a regional orthopaedic centre in South West Britain.
o The multivariate analysis used a logistic regression model with LoS as the dependent
variable.
o Those aged over 70 were found to be significantly more likely to stay over 2 weeks.
x Dall et al., (2009) in their multivariate analysis of predictors of LoS for patients with
osteoarthritis also found that older patients stay longer in hospital.
x Cookson and Laudicella (2011) used English hospital records from 2001/2 to 2007/8 to
assess the impact of income deprivation on LoS in patients undergoing hip replacement.
o In 2001/2 after adjusting for casemix differences, patients from the most deprived
areas stayed 6% longer than other patients. This difference fell to 2% longer by
2007/8
o A higher number of diagnoses was associated with longer LoS
x Tien et al., (2009) identified the factors affecting hospital costs (charges) for hip procedures
in Taiwan from 1996 to 2004.
o Using multiple regression models to explain costs they found that patients younger
than 65 years of age had lower costs than those 65+.
x Clement et al., (2011) conducted a study of Scottish patients. Using data from 2006-2008,
they compared a prospectively selected group of patients aged > 80 years with a group
aged between 65 and 74 years having total hip replacement.
o They found that on average the older group stayed approximately 3 days longer than
those in the 65-74 age group (P<0.0001).
x The EuroDRG group carried out analysis on patient level data in 10 European countries to
identify the explanators of cost and LoS for the treatment of hip replacement (Geissler et
al., 2012).
o They found that a significant positive relationship between age and LoS. The effect
of age on costs is less clear
o Men had a significantly shorter LoS than women
o The higher the number of diagnoses and procedures, the higher the cost or longer
the LoS
o The revision of a hip implant leads to significantly longer LoS and higher costs in all
countries
Patient-level analysis
During 2007/8, 82,902 patients had a hip replacement in 151 hospitals, the mean cost amounting to
£5,499 and LoS to 12.3 days. Results from our analyses of differences among patients in their costs
and LoS are reported in Table 11. Significant (P<0.001) variables that explain cost and LoS are
highlighted in Box 16.
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Table 11: Cost and LoS in hip replacement patients: patient-level analysis
Log of cost LoS #
Explanatory variable mean sd Full Model Partial Model Full Model Partial Model
ɴ se ɴ se ɴ se ɴ se
Age1: 1-63 0.208 0.406 -0.0080** 0.003 -0.0082** 0.003 0.922*** 0.006 0.920*** 0.006
Age2: 64-71 0.193 0.395 ref ref ref ref ref ref ref ref
Age3: 72-77 0.206 0.405 0.004 0.003 0.002 0.003 1.112*** 0.007 1.116*** 0.008
Age4: 78-83 0.189 0.391 0.0124*** 0.003 0.0102*** 0.003 1.265*** 0.009 1.278*** 0.010
Age5: 84+ 0.204 0.403 0.0280*** 0.004 0.0245*** 0.004 1.385*** 0.011 1.389*** 0.012
Gender 0.339 0.473 0.002 0.002 0.000 0.002 0.950*** 0.004 0.944*** 0.005
Socioeconomic status 0.140 0.106 0.007 0.010 0.006 0.010 1.238*** 0.028 1.239*** 0.029
Emergency admission DV 0.367 0.482 0.0397*** 0.009 -0.017 0.009 1.246*** 0.019 1.357*** 0.020
Transfer-in DV 0.032 0.175 -0.0302*** 0.007 -0.0382*** 0.007 1.042* 0.017 1.045** 0.017
Transfer-out DV 0.110 0.313 0.0320*** 0.004 0.0319*** 0.004 1.123*** 0.010 1.161*** 0.010
Total number diagnoses 4.071 2.837 0.0069*** 0.001 0.0061*** 0.001 1.066*** 0.002 1.090*** 0.002
Total number procedures 2.555 1.215 0.0214*** 0.001 0.0164*** 0.001 1.098*** 0.003 1.108*** 0.003
One non-severe Charlson comorbidity 0.220 0.414 0.004 0.002 0.003 0.002 1.020** 0.006 1.002 0.006
At least 1 severe or 2 non-severe Charlson comorbidities 0.100 0.300 0.000 0.004 -0.001 0.004 1.003 0.009 0.962*** 0.009
Hypertension comorbidity DV 0.373 0.483 -0.0093*** 0.002 -0.0093*** 0.002 0.918*** 0.005 0.908*** 0.005
Obesity comorbidity DV 0.014 0.118 0.0153* 0.006 0.0157* 0.006 1.022 0.017 1.015 0.018
HRG1: HB12B DV; Major Hip Procedures for non Trauma Category 1 w cc 0.305 0.461 ref ref ref ref ref ref ref ref
HRG2: HB14C DV; Intermediate Hip Procedures for non Trauma Category 1 w/o cc 0.014 0.117 -0.7731*** 0.018 -0.7192*** 0.018 0.467*** 0.018 0.452*** 0.018
HRG3: HB14B DV; Intermediate Hip Procedures for non Trauma Category 1 w cc 0.028 0.164 -0.5978*** 0.014 -0.5433*** 0.013 0.612*** 0.017 0.585*** 0.017
HRG4: HB12C DV; Major Hip Procedures for non Trauma Category 1 w/o cc 0.215 0.410 -0.0715*** 0.003 -0.0737*** 0.003 0.969*** 0.006 0.997 0.007
HRG5: HB12A DV; Major Hip Procedures for non Trauma Category 1 w mcc 0.034 0.181 0.2291*** 0.005 0.2334*** 0.005 1.349*** 0.017 1.371*** 0.018
HRG6: HA13C DV; Intermediate Hip Procedures for Trauma w/o cc 0.028 0.165 -0.0839*** 0.014 -0.1321*** 0.013 1.090*** 0.027 1.137*** 0.025
HRG7: HA13B DV; Intermediate Hip Procedures for Trauma w icc 0.110 0.313 -0.021 0.013 -0.0692*** 0.012 1.086*** 0.023 1.108*** 0.021
HRG8: HB11B DV; Major Hip Procedures for non Trauma Category 2 w cc 0.012 0.107 0.1301*** 0.012 0.1140*** 0.011 1.213*** 0.030 1.184*** 0.030
HRG9: HA13A DV; Intermediate Hip Procedures for Trauma w mcc 0.079 0.269 0.2003*** 0.013 0.1661*** 0.012 1.228*** 0.027 1.268*** 0.025
HRG10: VA04Z DV; Spine Hip Femur or Limb Procedures for Multiple Significant Trauma 0.014 0.119 0.0567*** 0.015 0.022 0.014 1.143*** 0.031 1.148*** 0.029
HRG11: HA05Z DV; Reconstruction Procedures Category 2 0.039 0.193 0.1827*** 0.008 0.1093*** 0.006 1.252*** 0.019 1.256*** 0.016
HRG12: HA04C DV; Reconstruction Procedures Category 3 w/o cc 0.013 0.112 0.2820*** 0.015 0.1323*** 0.011 1.393*** 0.039 1.404*** 0.033
HRG13: HA12B DV; Major Hip Procedures Category 1 for Trauma w cc 0.033 0.179 0.1331*** 0.012 0.1294*** 0.012 1.217*** 0.026 1.220*** 0.026
HRG14: HA04B DV; Reconstruction Procedures Category 3 w cc 0.026 0.159 0.4714*** 0.012 0.3288*** 0.006 1.492*** 0.033 1.466*** 0.021
HRG15: Other non-reference HRG DV 0.051 0.220 -0.010 0.012 -0.0383** 0.012 1.369*** 0.024 1.472*** 0.026
Fracture of femur if main/secondary diagnosis = S72 or M84 or M96 or S324 0.295 0.456 0.0918*** 0.011 0.1127*** 0.011 1.130*** 0.019 1.156*** 0.020
Replacement of head of femur partial hip replacement 0.281 0.449 -0.0797*** 0.009 1.093*** 0.017
Revision change or removal of hip replacement 0.085 0.279 -0.1591*** 0.011 0.979 0.017
Multiple episode DV 0.140 0.347 -0.0468*** 0.004 1.413*** 0.012
Mortality DV 0.034 0.180 -0.010 0.007 0.761*** 0.014
Adverse event DV 0.012 0.109 0.0208* 0.010 1.085*** 0.024
Infection DV: UTI 0.036 0.185 0.0344*** 0.006 1.151*** 0.015
Infection DV: post-operative infection 0.009 0.097 0.0647*** 0.013 1.313*** 0.028
Infection DV: C difficile 0.007 0.085 0.0607*** 0.015 1.554*** 0.038
Constant 8.4526*** 0.004 8.4637*** 0.004 4.124*** 0.039 3.823*** 0.036
alpha 0.203*** 0.002 0.220*** 0.002
N 82902 82902 82902 82902
r2_a / adjusted deviance r^2 0.509 0.501 0.647 0.625
# Exponentiated coefficients; DV: dummy variable; w: with; w/o: without; cc: complications and comorbidities; icc: intermediate cc; mcc: major cc; UTI: urinary tract infection. * p < 0.05, ** p < 0.01, *** p < 0.001
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Box 16: Patient characteristics that are significant explanators of variations in cost or hip replacement
Variables Our Findings
Dependent
variables (mean)
Cost  £5,499
LoS  12.3
Demographics Patients aged over 77 had significantly higher costs than the reference group aged 64-71.
LoS was positively associated with patient age.
Female patients and patients living in poorer areas also had longer hospital stays.
Admission/
Discharge
Emergency cases cost 4%more and resulted in 25% longer stays.
Transfers out cost 3%more and hospital stays were 12% longer.
However, patients transferred in had 3% lower costs than patients treated in a single hospital.
Patients cared for by more than one consultant had 5% lower costs but 41% longer LoS.
Case
Complexity
Where a greater number of diagnoses or procedures was recorded, patient cost and LoS were higher,
while a diagnosis of hypertension was associated with 1% lower costs and an 8% shorter LoS.
If quality variables were not included, patients diagnosed with at least 2 non-severe, or one severe
Charlson comorbidity, had 4% shorter LoS compared with patients without a diagnosed Charlson
comorbidity. However, this variable was insignificant when quality was adjusted for.
HRGs The range of circumstances in which a hip replacement procedure is performed is highlighted by the
number of HRG dummy variables containing at least 1% of cases. Adjustments are made for the
initial admission being due to trauma, categories of procedure, degree of complications and the
inclusion of reconstruction.
Relative to the reference HRG Major Hip Procedures for non Trauma Category 1 with complications
(HB12B), the impact on cost of other specified HRGs ranged from 54% lower than the reference HRG
(HB14C) to 60% higher (HA04B).
The same HRGs had the largest impact on LoS, ranging from 53% lower than the reference HRG to
49% higher.
Treatment
Specific
Patients diagnosed with a hip fracture had 10% higher costs and 13% longer LoS.
Partial hip replacements were 8% cheaper but patients stayed 9% longer than full replacement cases.
Costs were 15% lower for revision procedures.
Quality In hospital mortality was associated with 24% shorter LoS.
Patient costs and LoS were both higher when the patient was diagnosed with a UTI, post operative
infection or C. difficile.
LoS was also significantly longer when an adverse event occurred.
Hospital performance
After adjusting for casemix differences, there was less variation among hospitals in the average costs
of hip replacement compared with other conditions, ranging from 7% below to 6% above the
national average. The variation in average LoS was larger (from 36% below to 53% above the
national mean). There was a low correlation between average costs and LoS (r=0.28; P=0.0004),
which is partly a reflection of the limited variation in average costs. This low correlation explains why
hospitals with low average costs did not necessarily have low average LoS. Nevertheless some
hospitals appeared at the extreme upper end of both distributions, having both high costs and LoS.
This is evident for Queen Elizabeth Hospital NHS Trust, St Helens & Knowsley Hospitals NHS Trust
and Sheffield Teaching Hospitals NHS Foundation Trust.
Figure 15: Hospital fixed effects: hip replacement
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Box 17: Hospitals in top/bottom 5% by rank: hip replacement
cost
rank
LoS
rank
Hospital Name LoS
rank
cost
rank
Hospital Name
1 86 The Royal Wolverhampton
Hospitals NHS Trust
1 27 West Suffolk Hospitals NHS Trust
2 30 North Cheshire Hospitals NHS Trust 2 83 Taunton & Somerset NHS Trust
3 24 South Warwickshire General
Hospitals NHS Trust
3 38 Royal West Sussex NHS Trust
4 151 Queen Mary's Sidcup NHS Trust 4 52 Northern Devon Healthcare NHS
Trust
5 83 Shrewsbury & Telford Hospital NHS
Trust
5 54 West Dorset General Hospitals NHS
Trust
6 11 Weston Area Health NHS Trust 6 69 South Devon Healthcare NHS
Foundation Trust
7 95 Barts & The London NHS Trust 7 16 The Queen Elizabeth Hospital
King's Lynn NHS Trust
8 107 University Hospital Birmingham
NHS Foundation Trust
8 47 Heatherwood & Wexham Park
Hospitals NHS Trust
144 100 North Cumbria Acute Hospitals
NHS Trust
144 141 Sheffield Teaching Hospitals NHS
Foundation Trust
145 49 Gateshead Health NHS Foundation
Trust
145 59 Blackpool, Fylde & Wyre Hospitals
NHS Trust
146 134 Whipps Cross University Hospital
NHS Trust
146 151 Queen Elizabeth Hospital NHS Trust
147 93 Bromley Hospitals NHS Trust 147 20 East & North Hertfordshire NHS
Trust
148 54 Northern Lincolnshire & Goole
Hospitals NHS Trust
148 130 St George's Healthcare NHS Trust
149 150 St Helens & Knowsley Hospitals
NHS Trust
149 129 Central Manchester & Manchester
Children's University Hospitals NHS
Trust
150 27 Royal National Orthopaedic
Hospital NHS Trust
150 149 St Helens & Knowsley Hospitals
NHS Trust
151 146 Queen Elizabeth Hospital NHS Trust 151 4 Queen Mary's Sidcup NHS Trust
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Knee replacement
Literature review
x Tien et al., (2009) explored the factors affecting hospital charges for knee procedures in
Taiwan from 1996 to 2004.
o Using multiple regression models to predict costs they found that patients younger
than 65 years of age had lower costs than those equal to or over 65.
x Macario et al., (1997) analysed a random sample of 94 inpatients having knee replacement
to determine whether the Charlson comorbidity index was a good predictor of hospital
costs and LoS.
o They found that the Charlson was a significant predictor of costs for knee
replacement. A one unit increase in the Charlson comorbidity index score resulted in
an estimated increase in hospital costs of $1,229 (P=0.003).
x Clement et al., (2011) collected prospective data on Scottish patients over the period 2006-
2008, They compared a group of patients aged 80 or over with patients aged between 65
and 74 years having total knee replacement.
o On average, the older group stayed approximately 2 days longer than the younger
patients (P<0.0001).
x Research carried out by the EuroDRG group analysing the determinants of costs and LoS
for the treatment of knee replacement across 10 countries (Chiarello et al., 2012) found
o In general, the higher the number of diagnoses and procedures the higher the cost
and longer the LoS
o However, in England the total number of procedures was negatively associated with
cost, perhaps because the cost impact was captured by HRGs
o in most countries, revisions of the knee were significantly more costly while the
effect on LoS was mixed
o Patients transferred to other hospitals were significantly more costly in most
countries.
Patient-level analysis
Data were available for 62,034 patients having a knee replacement in 147 hospitals. Results of our
analyses of their costs and LoS are reported in Table 12. Patient characteristics that are significant
(P<0.001) explanators of variations in cost or LoS are summarised in Box 18.
Box 18: Patient characteristics that are significant explanators of variations in knee replacement
Variables Our Findings
Dependent variables
(mean)
Cost  £4,452
LoS  6.9
Demographics Patients aged over 73 had higher costs than the reference age group 63-68.
LoS increased with age. Female patients and patients from poorer areas had longer LoS.
Admission/
Discharge
Emergency spells were 48% longer than elective spells.
Patients transferred to another hospital had 4% higher costs and 30% longer LoS.
LoS was 16% longer for those transferred in, but this was no longer significant at the 0.1% level once quality was
adjusted for. Patients cared for by more than one consultant stayed 61% longer than those who were under the
care of a single consultant throughout their time in hospital.
Case
Complexity
An additional diagnosis or procedure increased patient LoS.
Patients diagnosed with hypertension had 7% shorter LoS.
HRGs Relative to the base HRG Major Knee Procedures for Non-Trauma cat 2 with complications (HB21B), patient
cost was 18% lower in the absence of complications (HB21C) but 39% higher when major complications occurred
(HB21A). Patients categorised to Reconstruction procedures category 1 (HA06Z), had the lowest costs, 23%
lower than the reference group.
The relationships between patient HRG and LoS moved in the same direction as those between HRG and cost,
except that LoS was higher among patients having reconstruction.
Treatment
Specific
The use of a revision procedure increased patient cost by 18% and LoS by 21%
Quality Less than 1% of patients experienced infections or adverse events. For those that did, LoS was significantly longer
in the presence of an adverse event (23%), UTI (14%), wound infection (31%) or C. difficile (50%).
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Table 12: Cost and LoS in knee replacement patients: patient-level analysis
Log of cost LoS #
Explanatory variable mean sd Full Model Partial Model Full Model Partial Model
ɴ se ɴ se ɴ se ɴ se
Age 1: 1 to 62 0.226 0.418 -0.0035 0.003 -0.0041 0.003 0.960*** 0.006 0.960*** 0.006
Age 2: 63 to 68 0.203 0.402 ref ref ref ref ref ref ref ref
Age 3: 69 to 73 0.200 0.400 0.0048 0.003 0.0043 0.003 1.063*** 0.007 1.064*** 0.007
Age 4: 74 to 78 0.194 0.395 0.0099*** 0.003 0.0098*** 0.003 1.167*** 0.008 1.168*** 0.008
Age 5: 79+ 0.178 0.383 0.0174*** 0.003 0.0174*** 0.003 1.337*** 0.009 1.348*** 0.01
Gender 0.421 0.494 -0.0063** 0.002 -0.0050* 0.002 0.933*** 0.004 0.933*** 0.004
Socioeconomic status 0.146 0.110 0.0215* 0.009 0.0197* 0.009 1.237*** 0.026 1.240*** 0.027
Emergency admission DV 0.008 0.090 0.0192 0.032 0.0374 0.033 1.477*** 0.053 1.703*** 0.062
Transfer-in DV 0.004 0.063 0.0163 0.025 0.0233 0.025 1.157** 0.052 1.157*** 0.049
Transfer-out DV 0.024 0.153 0.0393*** 0.008 0.0387*** 0.008 1.298*** 0.024 1.314*** 0.025
Total number diagnoses 3.083 2.013 0.0021* 0.001 0.0047*** 0.001 1.057*** 0.002 1.075*** 0.002
Total number procedures 2.377 0.938 -0.0037 0.002 -0.002 0.002 1.067*** 0.004 1.084*** 0.004
One non-severe Charlson comorbidity 0.201 0.400 0.0005 0.003 -0.0018 0.003 1.005 0.006 0.993 0.006
At least 1 severe or 2 non-severe Charlson comorbidities 0.050 0.217 0.0064 0.005 0.0008 0.005 1.037** 0.013 1.02 0.014
Hypertension comorbidity DV 0.418 0.493 -0.0029 0.003 -0.0064* 0.003 0.934*** 0.006 0.922*** 0.006
Obesity comorbidity DV 0.025 0.157 0.0094 0.005 0.005 0.005 1.011 0.013 0.995 0.013
HRG1: HB21B DV; Major Knee Procedures for non trauma cat 2 w cc 0.547 0.498 ref ref ref ref ref ref ref ref
HRG2: HB21C DV; Major Knee Procedures for non trauma cat 2 w/o cc 0.348 0.476 -0.1992*** 0.003 -0.1978*** 0.003 0.962*** 0.007 0.978** 0.007
HRG3: HA06Z DV; Reconstruction Procedures cat 1 0.027 0.162 -0.2644*** 0.012 -0.2593*** 0.013 1.376*** 0.023 1.368*** 0.023
HRG4: HB21A DV; Major Knee procedures for non trauma cat 2 w mcc 0.050 0.218 0.3302*** 0.008 0.3337*** 0.007 1.342*** 0.018 1.398*** 0.017
HRG5: Other non-reference HRG DV 0.028 0.164 -0.2943*** 0.017 -0.2282*** 0.017 1.040* 0.02 1.168*** 0.024
Revision of knee replacement procedure 0.048 0.214 0.1643*** 0.007 1.211*** 0.016
Procedure: transfusion of blood and blood components 0.005 0.069 -0.0282 0.015 1.023 0.03
Multiple episode DV 0.030 0.170 0.0306** 0.01 1.605*** 0.032
Mortality DV 0.002 0.047 0.0153 0.038 0.837 0.08
Adverse event DV 0.009 0.093 0.0243 0.019 1.232*** 0.035
Infection DV: UTI 0.006 0.075 0.027 0.025 1.135*** 0.041
Infection DV: post-operative infection 0.002 0.050 -0.0155 0.038 1.314*** 0.072
Infection DV: C difficile 0.001 0.026 0.0194 0.07 1.495*** 0.139
Constant 8.3673*** 0.006 8.3637*** 0.006 4.265*** 0.052 4.000*** 0.051
alpha 0.083*** 0.002 0.092*** 0.002
N 62034 62034 62034 62034
r2_a / adjusted deviance r^2 0.723 0.718 0.435 0.408
# Exponentiated coefficients; DV: dummy variable; w: with; w/o: without; cc: complications and comorbidities; mcc: major cc; UTI: urinary tract infection.
* p < 0.05, ** p < 0.01, *** p < 0.001
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Hospital performance
The variation among hospitals in the average costs of knee replacement ranged from 14% below to
10% above the national average, which was narrower than the variation in LoS (from 52% below to
82% above the national mean LoS). Compared to hip replacement, there was a weaker correlation
between average costs and LoS (r=0.18; P=0.0325). This relationship was also apparent in the
extremes of the distributions. For instance, Kingston Hospital NHS Trust and Weston Area Health
NHS Trust were among the hospitals with the lowest costs and shortest LoS nationally. At the other
end of the scale, a number of hospitals had higher costs and longer LoS, noticeably Queen Elizabeth
Hospital NHS Trust, Newham University Hospital NHS Trust, St Helens & Knowsley Hospitals NHS
Trust, Airedale NHS Trust and The Lewisham Hospital NHS Trust.
Figure 16: Hospital fixed effects: knee replacement
Box 19: Hospitals in top/bottom 5% by rank: knee replacement
cost
rank
LoS
rank
Hospital Name LoS
rank
cost
rank
Hospital Name
1 100 Shrewsbury & Telford Hospital NHS
Trust
1 6 Kingston Hospital NHS Trust
2 67 Blackpool, Fylde & Wyre Hospitals NHS
Trust
2 93 West Suffolk Hospitals NHS Trust
3 51 The Royal Orthopaedic Hospital NHS
Foundation Trust
3 134 Gateshead Health NHS Foundation Trust
4 60 North Cheshire Hospitals NHS Trust 4 7 Weston Area Health NHS Trust
5 136 North Hampshire Hospitals NHS Trust 5 112 Worthing & Southlands Hospitals NHS Trust
6 1 Kingston Hospital NHS Trust 6 57 The Queen Elizabeth Hospital King's Lynn
NHS Trust
7 4 Weston Area Health NHS Trust 7 17 South Warwickshire General Hospitals NHS
Trust
141 138 Airedale NHS Trust 141 143 Newham University Hospital NHS Trust
142 146 St Helens & Knowsley Hospitals NHS
Trust
142 133 The Lewisham Hospital NHS Trust
143 141 Newham University Hospital NHS Trust 143 125 Kettering General Hospital NHS Trust
144 73 Salford Royal NHS Foundation Trust 144 69 Central Manchester & Manchester
Children's University Hospitals NHS Trust
145 36 Lancashire Teaching Hospitals NHS
Foundation Trust
145 147 Queen Elizabeth Hospital NHS Trust
146 75 Nuffield Orthopaedic Centre NHS Trust 146 142 St Helens & Knowsley Hospitals NHS Trust
147 145 Queen Elizabeth Hospital NHS Trust 147 127 St George's Healthcare NHS Trust
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Stroke (ischemic and haemorrhagic)
Literature review
x Reed et al., (2001) estimated inpatient costs, LoS, and in-hospital mortality for patients
with subarachnoid haemorrhage (SAH), intra-cerebral haemorrhage (ICH), ischemic
cerebral infarction (ICI), and transient ischemic attack (TIA) treated in US community
hospitals.
o Multivariate statistical techniques were used on patient level data to examine
patient, hospital and outcome-related factors associated with inpatient costs.
o They found that costs decreased with age.
x The EuroDRG partners used a hierarchical approach to measure the cost and LoS effects for
the treatment of stroke across Europe (Peltola, 2012).
o They found a linear relationship between age and LoS  the older the patient the
longer was the stay.
o The more diagnoses and procedures, the longer was LoS and the higher were costs.
o Patients transferred to another hospital had significantly longer LoS in almost all
countries
o Mortality significantly shortened LoS and was generally associated with lower costs.
o Contracting pneumonia significantly increased LoS and costs.
Patient-level analysis
In Table 13 we report results from our analyses of the costs and LoS for the 69,372 patients who
suffered a stroke and were treated in one of 149 hospitals during 2007/8. The mean cost of their
care amounted to £3,002, but these patients tended to have long hospital stays: mean LoS
amounted to 20.2 days. Patient characteristics that proved to be significant (P<0.001) explanators of
cost and LoS are summarised in Box 20 below.
Box 20: Patient characteristics that are significant expanators of variations in cost or LOS for stroke
Variables Our Findings
Dependent
variables (mean)
Cost  £3,002
LoS  20.2
Demographics When assessed at the 0.1% level, older patients had higher costs and longer LoS.
LoS was also higher among female patients.
Admission/
Discharge
Patients transferred between hospitals had higher costs and LoS than patients treated in a single hospital.
Patients admitted as emergencies had 23% shorter LoS than elective cases.
68% of stroke patients were cared for by more than one consultant during their time in hospital. These
patients were 29% more costly and stayed 58% longer than those under the care of a single consultant.
Case
Complexity
Patients with a higher number of diagnoses or procedures had higher costs and LoS.
Patients diagnosed with Charlson comorbidities had significantly shorter stays. This impact was larger if the
patient was diagnosed with 2 or more non-severe or a severe Charlson comorbidity.
Cost was also lower (by 4%) in patients diagnosed with 2 or more non-severe Charlson comorbidities or at
least 1 major comorbidity.
A recorded diagnosis of hypertension was associated with 7% lower LoS.
HRGs Patients categorised into (AA23Z) Haemorrhagic Cerebrovascular Disorders had 19% lower costs than the
reference HRG (AA22Z) Non-Transient Stroke or Cerebrovascular Accident or Nervous System Infection,
but there was no significant difference in LoS.
Treatment
Specific
A diagnosis of cerebral haemorrhage was associated with a 10% increase in patient cost, relative to the
base case of infarction.
LoS was shorter when patients suffered an intracerebral haemorrhage, but the statistical significance of
this finding was sensitive to whether or not quality was accounted for.
Patients diagnosed with an unspecified stroke had 6% lower costs and 19% shorter LoS than infarction
cases.
A diagnosis of pneumonia, hemiplegia or paraplegia was associated with increased patient cost and LoS.
Quality Mortality was associated with 11% lower costs and 29% shorter LoS (Figure 17); the occurrence of an
adverse event, UTI or C. difficile infection increased patient cost.
Two percent of patients suffered C. difficile, and their costs were higher by 39% and LoS was almost
doubled on average (96% longer).
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Table 13: Cost and LoS in stroke patients: patient-level analysis
Log of cost LoS #
Explanatory variable mean sd Full Model Partial Model Full Model Partial Model
ɴ se ɴ se ɴ se ɴ se
Age 1: <66 0.209 0.407 -0.057*** 0.008 -0.065*** 0.008 0.858*** 0.013 0.853*** 0.013
Age 2: 66-74 0.189 0.391 ref ref ref ref ref ref ref 0.000
Age 3: 75-81 0.230 0.421 0.045*** 0.007 0.039*** 0.007 1.115*** 0.015 1.089*** 0.014
Age 4: 82-86 0.187 0.390 0.076*** 0.007 0.070*** 0.007 1.212*** 0.017 1.170*** 0.016
Age 5: 87+ 0.185 0.388 0.075*** 0.007 0.061*** 0.008 1.252*** 0.018 1.173*** 0.016
Gender 0.475 0.499 -0.013** 0.005 -0.014** 0.005 0.934*** 0.008 0.930*** 0.008
Socioeconomic status 0.162 0.120 0.011 0.021 0.011 0.021 1.136** 0.045 1.128** 0.045
Emergency admission DV 0.955 0.207 0.004 0.019 0.039* 0.019 0.774*** 0.020 0.814*** 0.022
Transfer-in DV 0.084 0.278 0.179*** 0.013 0.161*** 0.013 1.253*** 0.027 1.212*** 0.027
Transfer-out DV 0.197 0.398 0.128*** 0.006 0.178*** 0.006 1.574*** 0.016 1.756*** 0.016
Total number diagnoses 5.652 3.260 0.026*** 0.001 0.041*** 0.001 1.104*** 0.002 1.139*** 0.002
Total number procedures 2.087 1.680 0.042*** 0.002 0.058*** 0.002 1.078*** 0.003 1.107*** 0.003
One non-severe Charlson comorbidity 0.272 0.445 -0.010 0.005 -0.025*** 0.005 0.965*** 0.010 0.925*** 0.009
At least 1 severe or 2 non-severe Charlson comorbidities 0.166 0.372 -0.041*** 0.007 -0.078*** 0.007 0.873*** 0.011 0.797*** 0.010
Hypertension comorbidity DV 0.477 0.499 -0.003 0.005 -0.011* 0.005 0.933*** 0.008 0.915*** 0.008
Obesity comorbidity DV 0.007 0.082 -0.031 0.028 -0.051 0.029 0.895* 0.044 0.880* 0.045
HRG1: AA22Z DV; Non-Transient Stroke or Cerebrovascular Accident Nervous system infection 0.799 0.401 ref ref ref ref ref ref ref ref
HRG2: AA23Z DV; Haemorrhagic Cerebrovascular Disorders 0.122 0.328 -0.212*** 0.027 -0.194*** 0.027 1.028 0.039 1.080 0.044
Other non-reference HRG DV 0.079 0.270 0.021 0.012 0.010 0.012 0.992 0.016 0.970 0.016
Intracerebral haemorrhage 0.138 0.345 0.101*** 0.026 0.036 0.025 0.943 0.034 0.867*** 0.033
Unspecified Stroke 0.246 0.431 -0.067*** 0.005 -0.088*** 0.006 0.806*** 0.009 0.789*** 0.009
Pneumonia 0.098 0.297 0.110*** 0.008 0.071*** 0.007 1.309*** 0.018 1.171*** 0.015
Secondary diagnosis: Hemiplegia or paraplegia 0.067 0.249 0.081*** 0.009 0.081*** 0.009 1.250*** 0.021 1.229*** 0.020
Multiple episode DV 0.638 0.481 0.255*** 0.006 1.576*** 0.017
Mortality DV 0.240 0.427 -0.112*** 0.006 0.713*** 0.009
Adverse event DV 0.031 0.174 0.105*** 0.013 1.362*** 0.028
Infection DV: UTI 0.090 0.286 0.115*** 0.008 1.360*** 0.018
Infection DV: post-operative infection 0.002 0.039 0.108 0.062 1.293** 0.103
Infection DV: C difficile 0.018 0.134 0.330*** 0.018 1.959*** 0.046
Constant 7.353*** 0.022 7.388*** 0.022 7.010*** 0.225 7.599*** 0.245
alpha 0.799*** 0.005 0.863*** 0.005
N 69372 69372 69372 69372
r2_a / adjusted deviance r^2 0.351 0.318 0.329 0.279
# Exponentiated coefficients; DV: dummy variable; UTI: urinary tract infection.
* p < 0.05, ** p < 0.01, *** p < 0.001
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Figure 17: Variation in LoS by mortality: stroke
Hospital performance
After adjusting for casemix differences, average hospital costs ranged from 29% below to 12% above
the national average; the corresponding figures for LoS were 92% to 202%. Of the 10 conditions we
analysed, the variation in LoS was greatest for stroke, equating to a three-fold difference between
the most efficient and least efficient hospitals (Figure 18).
There was a relatively strong positive relationship between average costs and LoS with r=0.41
(P<0.001). Some hospitals had both the lowest costs and LoS nationally, notably Royal Devon &
Exeter NHS Foundation Trust, Great Ormond Street Hospital for Children NHS Trust and Countess of
Chester Hospital NHS Foundation Trust. Great Ormond Street Hospital is identifiable on the cost
graph by its large confidence interval. Unsurprisingly, this hospital treated very few cases compared
with the other hospitals in the analysis. This helps explain the uncertainty around the estimate of
mean cost.
At the other extreme, those with very high average LoS also tended to have very high average costs,
with the following hospitals performing poorly whichever resource measure was used: The
Rotherham NHS Foundation Trust, Queen Mary's Sidcup NHS Trust, Mid Yorkshire Hospitals NHS
Trust, and Sheffield Teaching Hospitals NHS Foundation Trust. Hospitals with higher LoS also tended
to have a higher mortality rates for stroke patients. The hospital on the extreme right hand side of
the LoS graph is Queen Mary's Sidcup. The reason for this hospitals extremely high average LoS is
unclear, but a possible explanation is that there is an onsite rehabilitation unit.
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Figure 18: Hospital fixed effects: Stroke
Box 21: Hospitals in top/bottom 5% by rank: stroke
cost
rank
LoS
rank
Hospital Name LoS
rank
cost
rank
Hospital Name
1 138 Blackpool, Fylde & Wyre Hospitals
NHS Trust
1 9 Great Ormond Street Hospital For Children
NHS Trust
2 53 Southend University Hospital NHS
Foundation Trust
2 31 South Devon Healthcare NHS Foundation
Trust
3 7 Royal Devon & Exeter NHS
Foundation Trust
3 26 Royal West Sussex NHS Trust
4 93 Newham University Hospital NHS
Trust
4 12 Countess Of Chester Hospital NHS
Foundation Trust
5 45 Dudley Group Of Hospitals NHS
Trust
5 64 The Newcastle Upon Tyne Hospitals NHS
Foundation Trust
6 51 Derby Hospitals NHS Foundation
Trust
6 136 St George's Healthcare NHS Trust
7 19 Homerton University Hospital NHS
Foundation Trust
7 3 Royal Devon & Exeter NHS Foundation
Trust
143 113 Queen Elizabeth Hospital NHS
Trust
143 141 The Rotherham NHS Foundation Trust
144 66 The Hillingdon Hospital NHS Trust 144 140 Sheffield Teaching Hospitals NHS
Foundation Trust
145 91 Bedford Hospital NHS Trust 145 45 Calderdale & Huddersfield NHS Foundation
Trust
146 147 Mid Yorkshire Hospitals NHS Trust 146 114 Central Manchester & Manchester
Children's University Hospitals NHS Trust
147 136 Wrightington, Wigan & Leigh NHS
Trust
147 146 Mid Yorkshire Hospitals NHS Trust
148 134 Harrogate & District NHS
Foundation Trust
148 111 The Royal Bournemouth & Christchurch
Hospitals NHS Foundation Trust
149 149 Queen Mary's Sidcup NHS Trust 149 149 Queen Mary's Sidcup NHS Trust
English hospitals can improve their use of resources: an analysis of costs and length of stay for ten treatments 55
Performance within and across hospitals
We now assess whether the hospital effects were correlated across treatments. Having accounted
for the influence of patient characteristics, these effects capture the hospitals influence on resource
use. Thus, a higher hospital effect indicates higher resource use among this hospitals patients than
similar patients treated at other hospitals (Dormont and Milcent, 2004; Olsen and Street, 2008;
Street et al., 2012). As a consequence, these hospital effects can be interpreted as measures of
relative efficiency in managing costs or LoS.
As we ran separate regressions using log of cost and LoS for each of the 10 treatments, each of our
164 hospitals had a set of no more than 10 rankings for cost and up to 10 rankings for LoS. We
rescaled the rankings in order to make them comparable across treatments. For each treatment, the
bottom ranking hospital received a rank of 1 and the others received a value between 0 and 1
according to their relative positions. Therefore, the hospital ranked 28th in the CABG analysis had an
adjusted ranking of 1; and the hospital ranked 28th in the appendectomy analysis had an adjusted
ranking of 0.185 (=28/151).
We plotted the mean (rescaled) rankings for all 164 hospitals, to see whether any correlations across
the conditions were apparent (Figure 19 and Figure 20). Only 28 hospitals undertook CABG, so there
are comparatively few data points. The following relationships are apparent:
x The rankings for cholecystectomy were directly correlated with those of hernia. For
these two treatments, the correlation coefficient was 0.72 for the cost ranking and
0.59 in the LoS analysis. Both these coefficients were statistically significant at the 5%
level (using the Bonferroni adjustment)(Bland and Altman, 1995).
x In the LoS analysis, there was a positive correlation between hospital ranking for
appendectomy and cholecystectomy (r=0.54) but the correlation between these two
treatments was not statistically significant in the cost rankings (r=0.21; P = 0.4436).
x Rankings for hip and knee replacement were also significantly correlated (costs:
r=0.54; LoS: r=0.71).
x No other statistically significant correlations were found.
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Figure 19: Efficiency rankings by cost: 164 hospitals across 10 types of treatment
Figure 20: Efficiency rankings by LoS: 164 hospitals across 10 types of treatment
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Figure 21: Scatterplot showing hospital efficiency rank by number of types of treatment provided
We then explored the relationship between the number of treatments undertaken by a hospital and
the hospitals position within the distribution. Figure 21 plots the average rank for each hospital by
the number of conditions they treat. Rankings for cost are on the left, and LoS ranks are shown on
the right hand side of the figure. The x-axis shows the mean hospital rank, which ranges between 0
(most efficient) to 1 (least efficient).
There are two striking features about this figure:
x First, hospitals are polarised in their scope: they either treat a small number of conditions
(three or fewer, so are located on the lower part of the graph) or they treat most of the ten
conditions we have analysed (upper region of the graph). There are no hospitals between
these extremes.
x Second, the hospitals at either extreme of the efficiency distribution  those furthest to the
left or furthest to the right  are invariably hospitals that treat a small number of
conditions. However, amongst those that treat few conditions, efficiency ranking varies
across the whole range; this is also true of the hospitals that treat a high number of
conditions.
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Conclusions
In this work, we set ourselves three study questions:
1. To what extent is resource use driven by the characteristics of patients and of the type and
quality of care they receive?
2. After taking these characteristics into account, to what extent is resource use related to
the hospital in which treatment takes place?
3. Are conclusions robust to whether resource use is described by costs or by LoS?
The patient-level analyses explained between 32% (stroke) and 72% (breast cancer and knee
replacement) of the variation in cost. When LoS was the dependent variable, the corresponding
figures were 28% (stroke) and 63% (hip replacement). Looking across the ten treatment types, a
number of patterns emerge. Older age is generally associated with higher levels of resource use.
Being female is also associated with higher costs and longer stays, although this was not always
statistically significant. Where deprivation affected resource use, it more frequently drove up LoS
rather than cost.
A higher total number of recorded diagnoses was always associated with higher costs and longer
stays; the total number of recorded procedures had a similar impact on stay, but did not always
increase cost. If patients experienced adverse events, the main impact on resource use was a
lengthened stay in hospital.
For every condition considered, after accounting for a broad range of patient characteristics, we find
that there are hospitals where the average cost of treatment is significantly higher than the national
average. The challenge for these hospitals is to secure reductions in costs if they are to manage
financially under Payment by Results, where a fixed price applies to each treatment.
For some of these high costs hospitals, the average LoS of their patients is also significantly higher
than the national average. In such cases, these hospitals might secure reductions in costs by
reducing LoS. But a focus on LoS will not always solve the problem: the relationship between
average hospital costs and LoS is usually quite weak, with the highest correlation amounting to
r=0.41. Even at patient level, the correlation never amounts to more than r=0.50. As a consequence,
hospitals identified as having high costs are not always those with excessive LoS.
We explored a range of hospital characteristics that might explain variation in both average cost and
LoS, including measures of specialisation and of the volume of activity undertaken. But, with a
couple of exceptions, none of these characteristics proved significant explanators.
Instead the answers are likely to be specific to each hospital and two areas might merit further
attention. First, high costs may be due to how either indirect or overhead costs have been allocated
to the particular patients in question. If so, the problem might be easily solved by correcting the
costing process, which entails re-allocating shared costs from these patients to others. While mis-
allocation of shared costs may be a problem in some hospitals, it doesnt seem to be widespread, as
evidenced by the positive correlation in average costs for treatments where resources might be
shared, namely cholecystectomy and hernia (r=0.72) and hip and knee replacement (r=0.54). If costs
were mis-allocated between these conditions, the correlations would be negative.
Second, there may be problems with how care is organised in these high cost hospitals. It may be
that the only way to uncover the nature of these problems is by visiting the department in question.
Our analytical approach allows us to pinpoint the hospitals and the specific areas of operation where
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more detailed scrutiny is required. Managers should visit those departments with high costs to find
out why, knowing that it is not due to the particular characteristics of patients themselves. Failure to
identify and address high cost drivers will place the hospital at financial risk under Payment by
Results.
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